Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
Artikkelit kansainvälisissä tieteellisissä aikakauslehdissä
Articles in international refereed scientific journals
|
|
1 |
Ahti J, Haaki W, Kieseppä T, Suvisaari J, Niemelä S, Suokas K, Torniainen-Holm M, Wegelius A, Kampman O, Lähteenvuo M, Paunio T, Tiihonen J, Hietala J, Isometsä ET. Suicidal acts and thoughts among persons with psychotic disorders in the Finnish
SUPER study. Eur Psychiatry 2025:68(1):e99.
|
|
2 |
Antikainen R, Turunen H, Kuosmanen A, Haatainen K. Issues Related to Patient Participation in Psychiatric Hospital Care-An Integrative Literature Review of Patient Safety Research. J Clin Nurs 2025:34(4):1225-1239.
|
|
3 |
Cederlöf E, Holm M, Kämpe A, Ahola-Olli A, Kantojärvi K, Lähteenvuo M, Ahti J, Hietala J, Häkkinen K, Isometsä E, Tuulio-Henriksson A, Kampman O, Lahdensuo K, Lönnqvist J, Tiihonen J, Turunen H, Wegelius A, Veijola J, Kieseppä T, et al. Sleep and
schizophrenia polygenic scores in non-affective and affective psychotic disorders. Psychol Med 2025:55:e117.
|
|
4 |
Correll CU, Emborg Mafi C, Fagiolini A, Seerden P, Seifritz E, Tiihonen J, Vita A, Citrome L. Brexpiprazole in the Management of Schizophrenia: A Consensus Report of Best Practices From Acute to Maintenance Treatment. Neuropsychiatr Dis Treat
2025:21:1857-1883.
|
|
5 |
Cullen AE, de Montgomery CJ, Pettersson E, Akhtar A, Norredam M, Taipale H, Mittendorfer-Rutz E. Associations of migrant and refugee status with physical comorbidity and mortality among young adults with incident non-affective psychotic disorders.
BMC Public Health 2025:25(1):2680.
|
|
6 |
de Montgomery CJ, Rasmussen AF, Bergström J, Taipale H, Akhtar A, Krasnik A, Nųrredam M, Mittendorfer-Rutz E, Cullen AE. Refugee Migration Background and Healthcare Contacts Prior to First-Episode Psychosis in Young Adults in Denmark and Sweden: Are
Patterns Consistent Across Countries? Early Interv Psychiatry 2025:19(4):e70039.
|
|
7 |
Ekholm O, Herling SF, Lykke C, Skurtveit S, Hamina A, Sjųgren P, Kurita GP. Monitoring Chronic Non-Cancer Pain in Denmark Over Two Decades: Prevalence, Mental Health and Loneliness. Eur J Pain 2025:29(2):e4776.
|
|
8 |
Ellilä V, Taipale H, Tiihonen J, Mittendorfer-Rutz E, Niemelä S. Relapse in substance-induced psychosis and associated risk factors. A Nationwide register-linkage study from Sweden. Addiction 2025:120(7):1422-1430.
|
|
9 |
Ermis C, Taipale H, Tanskanen A, Vieta E, Correll CU, Mittendorfer-Rutz E, Tiihonen J. Real-world effectiveness of pharmacological maintenance treatment of bipolar depression: a within-subject analysis in a Swedish nationwide cohort. Lancet
Psychiatry 2025:12(3):198-207.
|
|
10 |
Ermis C, Taipale H, Tiihonen J. Bipolar depression management needs randomised controlled trial evidence - Authors' reply. Lancet Psychiatry 2025:12(5):331-332.
|
|
11 |
Gkogka A, Malwade S, Koskuvi M, Ohtonen S, Molnar E, Bose R, Ceccatelli S, Koistinaho J, Tiihonen J, Schalling M, Samudyata S, Sellgren CM. Human oligodendrocyte progenitor cells mediate synapse elimination through TAM receptor activation. Nat
Commun 2025:16(1):10612.
|
|
12 |
Gustafsson TT, Taipale H, Lähteenvuo M, Tanskanen A, Svirskis T, Huoponen S, Tiihonen J. Cause-specific mortality in treatment-resistant major depression: Population-based cohort study. J Affect Disord 2025:1(368):136-142.
|
|
13 |
Halstead S, Yap CX, Warren N, Agarwal SM, Brand BA, Chan SKit, Cipriani A, Correll CU, Crossley N, D'Ambrosio E, Emsley R, Firth J, Gaughran F, Gee S, Hahn M, ..., Taipale H, Taylor D, Tiihonen J, et al. Holistic prevention and management of physical
health side-effects of psychotropic medication: second report of the Lancet Psychiatry Physical Health Commission. Lancet Psychiatry 2025:12(9):673-699.
|
|
14 |
Hamina A, McDonald R, Skurtveit S. Pregabalin is associated with a higher overdose risk but the risk with gabapentin is not negligible. Pain 2025:166(2):463-464.
|
|
15 |
Herttua K, Scola G, Paljarvi T, Fazel S. Associations between antidepressants and risk of suicidal behavior and violent crimes in personality disorder. Eur Psychiatry 2025:68(1):e28.
|
|
16 |
Hietala E, Solismaa A, Lähteenvuo M, Ahola-Olli AV, Häkkinen K, Suokas K, Isometsä E, Suvisaari J, Kieseppä T, Holm M, Tiihonen J, Lönnqvist J, Hietala J, Wegelius A, Lahdensuo K, Haaki W, Kampman O. Influence of CYP2D6 phenotype on adherence,
adverse effects, and attitudes in aripiprazole and risperidone users. Acta Neuropsychiatr 2025:37:e54.
|
|
17 |
Holm M, Tanskanen A, Tiihonen J, Taipale H. The Role of Antipsychotics and Mood Stabilizers in Preventing Sickness Absence Among Employed Individuals With Bipolar Disorder: A Nationwide Register-Based Study. Acta Psychiatr Scand
2025:152(2):104-111.
|
|
18 |
Howes OD, Bukala BR, Chen EY, Correll CU, Hasan A, Honer WG, Kane JM, Leucht S, Siafis S, Agid O, Akena D, Arango C, Atwoli L, Barnes TR, Birnbaum ML, Bitter I, Breier A, Buchanan RW, ..., Tiihonen J, et al. Relapse in Schizophrenia: A Systematic
Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve Them. Am J Psychiatry 2025:182(11):969-983.
|
|
19 |
Hųydal Nestvold H, Haarr E, Hamina A, Hjellvik V, Skurtveit S, Odsbu I. Incidence of and Determinants for Substance Use Disorders Among Individuals With Long-Term Prescription Opioid Use: A Population-Based Cohort Study. Pharmacoepidemiol Drug
Saf 2025:34(9):e70212.
|
|
20 |
Kautzky A, Petterson E, Amin R, Akhtar A, Tanskanen A, Taipale H, et al. Treatment Patterns for Incident Bipolar Disorder Among Nonrefugee Immigrants, Refugees, Second-Generation Immigrants, and Host Population in Sweden. Bipolar Disord
2025:27(3):192-204.
|
|
21 |
Kuokkanen R. The feasibility and acceptability of metacognitive therapy in a forensic setting: a case report of chronic paranoid schizophrenia with persistent depressive symptoms. Psychiatry Research Case Reports 2025:4(2):100282.
|
|
22 |
Laitinen H, Tiihonen M, Tanskanen A, Tiihonen J, Lieslehto J, Koponen M, Taipale H. Long-Term Use of Benzodiazepines and Related Drugs in Persons With Major Depressive Disorder. Brain Behav 2025:15(11):e71085.
|
|
23 |
Leppänen H, Kampman O, Autio R, Tanskanen A, Taipale H, Karolaakso T, Rissanen P, Näppilä T, Pirkola S. Socioeconomic status, antidepressant use, and return to work after disability due to common mental disorders. Eur Psychiatry
2025:68(1):e79.
|
|
24 |
Lieslehto J, Tiihonen J, Lähteenvuo M, Kautzky A, Akhtar A, Amin R, Įrmannsdóttir B, Leucht S, Correll CU, Mittendorfer-Rutz E, Tanskanen A, Taipale H. Relapse risk prediction in patients with first-episode bipolar disorder: development, external
validation, and pharmacotherapy associations of a machine learning model. Mol Psychiatry 2025:30(12):5722-5730.
|
|
25 |
Lieslehto J, Tiihonen J, Lähteenvuo M, Kautzky A, Akhtar A, Įrmannsdóttir B, Leucht S, Correll CU, Mittendorfer-Rutz E, Tanskanen A, Taipale H. Machine learning-based mortality risk assessment in first-episode bipolar disorder: a transdiagnostic
external validation study. EClinicalMedicine 2025:81:103108.
|
|
26 |
Lintunen J, Hamina A, Lähteenvuo M, Paljärvi T, Tanskanen A, Tiihonen J, Taipale H. Dosing levels of antipsychotics and mood stabilizers in bipolar disorder: A Nationwide cohort study on relapse risk and treatment safety. Acta Psychiatr Scand
2025:151(1):81-91.
|
|
27 |
Lumén K, Louheranta O, Kuosmanen L. 'We Are the Cornerstone of This Hospital': First-Hand Accounts of Expert-By-Experience Practices in Forensic Psychiatry in Finland. Int J Ment Health Nurs 2025:34(3):e70079.
|
|
28 |
Luykx JJ, Colgan M, Vieta E, Hamina A, Schulte PF, Correll CU, Mittendorfer-Rutz E, Siskind D, Lieslehto J, Tanskanen A, Tiihonen J, Taipale H. Transdiagnostic effectiveness and safety of clozapine in individuals with psychotic, affective, and
personality disorders: nationwide and meta-analytic comparisons with other antipsychotics. Lancet Psychiatry 2025:12(12):921-931.
|
|
29 |
Luykx JJ, Corbeil O, Kärkkäinen O, Tanskanen A, Mittendorfer-Rutz E, Tiihonen J, Taipale H. Long term safety of ADHD medication in patients with schizophrenia spectrum disorders. Mol Psychiatry 2025:30(10):4859-4867.
|
|
30 |
Lähteenvuo M, Tiihonen J, Solismaa A, Tanskanen A, Mittendorfer-Rutz E, Taipale H. Repurposing Semaglutide and Liraglutide for Alcohol Use Disorder. JAMA Psychiatry 2025:82(1):94-98.
|
|
31 |
Masvosva W, Lehtonen M, Martiskainen M, Tiihonen J, Karhunen PJ, Hanhineva K, Rysä J, Kok E, Kärkkäinen O. Metabolic Alterations in Human Post-Mortem Frontal Cortex and Cerebrospinal Fluid Associated With High Levels of Nicotine Metabolite Cotinine.
Addict Biol 2025:30(6):e70064.
|
|
32 |
McCutcheon RA, Pillinger T, Varvari I, Halstead S, Ayinde OO, Crossley NA, Correll CU, Hahn M, Howes OD, Kane JM, Kabir T, Konradsson-Geuken Å, Lennox B, Hui CL, Rossell SL, Solmi M, Sommer IE, Taipale H, Uchida H, et al. INTEGRATE: international
guidelines for the algorithmic treatment of schizophrenia. Lancet Psychiatry 2025:12(5):384-394.
|
|
33 |
Mellin D, Mittendorfer-Rutz E, de Montgomery CJ, Cullen AE, Taipale H. Initiation of antipsychotic medication among refugees, non-refugee migrants, second-generation migrants, and Swedish-born adults with incident non-affective psychotic disorders.
Soc Psychiatry Psychiatr Epidemiol 2025:60(12):2773-2784.
|
|
34 |
Nestvold H, Skurtveit S, Hamina A, Hjellvik V, Odsbu I. The risk of long-term opioid use among immigrants: a national registry-linkage study. Scand J Public Health 2025:53(7):764-775.
|
|
35 |
Niskanen M, Kärkkäinen O, Taipale H, Lieslehto J, Tiihonen J, Hamina A. Bipolar disorder and poisoning due to medicines or illegal substances. Acta Psychiatr Scand 2025:152(4):299-307.
|
|
36 |
Odsbu I, Hamina A, Hjellvik V, Handal M, Haram M, Tesli M, Tanskanen A, Taipale H. Initiation of Antipsychotics During the First Year After First-Episode Psychosis: A Population-Based Study. Acta Psychiatr Scand 2025:151(4):537-547.
|
|
37 |
Ojansuu I, Tiihonen J, Lähteenvuo M. Deaths by suicide during inpatient treatment among Finnish forensic psychiatric patients. Psychiatr Fenn 2025:56:234-239.
|
|
38 |
Ompad G, Cesta CE, Cohen J, Leinonen M, Taipale H, Li H, et al. Current Use of Common Data Models in the Nordic Countries. Pharmacoepidemiol Drug Saf 2025:34(11):e70242.
|
|
39 |
Orhan F, Malwade S, Khanlarkhani N, Gkogka A, Langeder A, Jungholm O, Koskuvi M, Lehtonen S, Schwieler L, Jardemark K, Tiihonen J, Koistinaho J, Erhardt S, Engberg G, Samudyata S, Sellgren CM. Kynurenic acid and promotion of activity-dependent
synapse elimination in schizophrenia. Am J Psychiatry 2025:182(4):389-400.
|
|
40 |
Paavola J, Huuskonen T, von Und Zu Fraunberg M, Koivisto T, Kämäräinen O, Lång M, Lähteenvuo M, Jääskeläinen JE, Huttunen J, Lindgren A. The predictive role of family history of antipsychotic drug use in poor outcomes following aneurysmal
subarachnoid hemorrhage (aSAH). Brain Spine 2025:5:104317.
|
|
41 |
Paljärvi T, Forton JT, Thompson C, Luciano S, Herttua K, Fazel S. Neuropsychiatric diagnoses after montelukast initiation in paediatric patients with asthma. Thorax 2025:80(1):9-15.
|
|
42 |
Rolova G, Engeland A, Pedersen L, Odsbu I, Hamina A, Skurtveit S. Mortality among patients with long-term prescription opioid use in Norway: a nationwide registry-based cohort study. Pain 2025:166(11):e555-e562.
|
|
43 |
Rolovį G, Engeland A, Pedersen L, Odsbu I, Hamina A, Skurtveit S. Reply to the Chen and Chen. Pain 2025:166(10):e493-e494.
|
|
44 |
Räsänen N, Tiihonen J, Koskuvi M, Trontti K, Cheng L, Hill AF, Lehtonen S, Vaurio O, Ojansuu I, Lähteenvuo M, Pietiläinen O, Koistinaho J. miRNA profiling of hiPSC-derived neurons from monozygotic twins discordant for schizophrenia. Schizophrenia
(Heidelb) 2025:11(1):21.
|
|
45 |
Sivak L, Ojansuu I, Tiihonen J, Lähteenvuo M, Forsman J. Sweden vs. Finland - forensic psychiatric care and subsequent recidivism in violent crime. Nord J Psychiatry 2025:79(4):314-320.
|
|
46 |
Solmi M, Croatto G, Fabiano N, Wong S, Gupta A, Fornaro M, Schneider LK, Rohani-Montez SC, Fairley L, Smith N, Bitter I, Gorwood P, Taipale H, Tiihonen J, Cortese S, Dragioti E, Rietz E, Nielsen RE, Firth J, Fusar-Poli P, et al. Sex-stratified
mortality estimates in people with schizophrenia: A systematic review and meta-analysis of cohort studies of 2,700,825 people with schizophrenia. Eur Neuropsychopharmacology 2025:91:56-66.
|
|
47 |
Solmi M, Thompson T, Cortese S, Estrade A, Agorastos A, Radua J, Dragioti E, Vancampfort D, Thygesen L, ..., Tiihonen J, et al. Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT): global and risk-group stratified
course of well-being and mental health during the COVID-19 pandemic in adolescents. J Am Acad Child Adolesc Psychiatry 2025:64(4):499-519.
|
|
48 |
Solmi M, Thompson T, Cortese S, Estradé A, Agorastos A, Radua J, Dragioti E, Vancampfort D, Thygesen LC, Aschauer H, Schlögelhofer M, Aschauer E, Schneeberger A, Huber CG, Hasler G, Conus P, Cuénod KQ, ..., Tiihonen J, et al. Collaborative outcomes
study on health and functioning during infection times (COH-FIT): Insights on modifiable and non-modifiable risk and protective factors for wellbeing and mental health during the COVID-19 pandemic from multivariable and network anal. Eur
Neuropsychopharmacology 2025:90:1-15.
|
|
49 |
Soppela H, Aaltonen M, Aho K, Heikkinen S, Kivisild A, Lehtonen A, Leppänen L, Mäki-Petäjä-Leinonen A, Rinnankoski I, Tervonen L, Tiihonen J, Lähteenvuo M, Haapasalo A, Portaankorva AM, Hartikainen P, Katisko K, Krüger J, Solje E. Criminal Behavior
in Early Onset Neurodegenerative Diseases. Eur J Neurol 2025:32(4):e70134.
|
|
50 |
Taipale H, Siskind D, Tanskanen A, Mittendorfer-Rutz E, Correll CU, Tiihonen J. Real-world effectiveness of clozapine augmentation with antidepressants: within-subject data evidence from two European nationwide cohorts. Lancet Psychiatry
2025:12(8):568-578.
|
|
51 |
Taipale H, Tanskanen A, Howes O, Correll CU, Kane JM, Tiihonen J. Comparative effectiveness of antipsychotic treatment strategies for relapse prevention in first-episode schizophrenia in Finland: a population-based cohort study. Lancet
Psychiatry 2025:12(2):122-130.
|
|
52 |
Tiihonen J, Tanskanen A, Mittendorfer-Rutz E, Howes OD, Correll CU, Siskind D, Taipale H. Effectiveness of clozapine augmentation with specific doses of other antipsychotics in schizophrenia: a meta-analysis from two nationwide cohorts. World
Psychiatry 2025:24(2):250-259.
|
|
53 |
Tiihonen J, Tanskanen A, Solmi M, Rubio JM, Correll CU, Kane JM, Taipale H. Continuous Dopamine D2 Receptor Blockade and Long-Term Outcome in First-Episode Schizophrenia. Am J Psychiatry 2025:182(4):341-348.
|
|
54 |
van der Horst MZ, de Boer N, ..., Tuppurainen H, ..., Lähteenvuo M, ..., Hallikainen T, et al. Determinants of patient satisfaction in clozapine users: results from the Clozapine International Consortium (CLOZIN). Schizophrenia (Heidelb)
2025:11(1):28.
|
|
55 |
van Deursen D, Mittendorfer-Rutz E, Taipale H, Pettersson E, McGuire P, Fusar-Poli P, Joyce DW, Albert N, Erlangsen A, Nordentoft M, Hjorthųj C, Cervenka S, Cullen AE. Prevalence and predictors of healthcare use for psychiatric disorders at 9 years
after a first episode of psychosis: a Swedish national cohort study. BMJ Ment Health 2025:28(1):e301248.
|
|
56 |
Vaurio O, Tiihonen J, Lähteenvuo M, Lieslehto J. Psychopathic traits associate with later schizophrenia. Acta Psychiatr Scand 2025:152(6):432-440.
|
|
57 |
Verdoux H, Bittner RA, Hasan A, Qubad M, Wagner E, Lepetit A, Arrojo-Romero M, Bachmann C, Beex-Oosterhuis M, Bogers J, Celofiga A, Cohen D, de Berardis D, de Hert M, de Las Cuevas C, Ebdrup BH, ..., Taipale H, Tiihonen J, Tuppurainen H, et al. The
time has come for revising the rules of clozapine blood monitoring in Europe. A joint expert statement from the European Clozapine Task Force. Eur Psychiatry 2025:68(1):e17.
|
|
58 |
Ahti J, Kieseppä T, Haaki W, Suvisaari J, Niemelä S, Suokas K, Holm M, Wegelius A, Kampman O, Lähteenvuo M, Paunio T, Tiihonen J, Hietala J, Isometsä E. General medical comorbidities in psychotic disorders in the Finnish SUPER study. Schizophrenia
(Heidelb) 2024:10(1):124.
|
|
59 |
Armannsdottir B, Taipale H, Akhtar A, Kautzky A, Björkenstam E, Lieslehto J, Tiihonen J, Lieslehto J, Amin R, Mittendorfer-Rutz E. Labor market marginalization in individuals with bipolar disorder: a Swedish nationwide register-based sibling
comparison study. Psychol Med 2024:54(16):1-11.
|
|
60 |
Bramness JG, Hjorthoj C, Niemelä S, Taipale H, Rognil EB. Discussing the concept of substance-induced psychosis (SIP). Psychol Med 2024:54(11):2852-2856.
|
|
61 |
Bramness JG, Hjorthųj C, Niemelä S, Taipale H, Rognli EB. Problematic diagnosis of substance-induced disorders in ICD-11. Eur Psychiatry 2024:67(1):e51.
|
|
62 |
Brand BA, Sommer IE, Gangadin SS, Tanskanen A, Tiihonen J, Taipale H. Real-World Effectiveness of Menopausal Hormone Therapy in Preventing Relapse in Women With Schizophrenia or Schizoaffective Disorder. Am J Psychiatry
2024:181(10):893-900.
|
|
63 |
Cederlöf E, Holm M, Taipale H, Tiihonen J, Tanskanen A, Lähteenvuo M, Lahdensuo K, Kampman O, Wegelius A, Isometsä E, Kieseppä T, Palotie A, Suvisaari J, Paunio T, et al. Antipsychotic medications and sleep problems in patients with schizophrenia.
Schizophr Res 2024:267:230-238.
|
|
64 |
Chen J, Mittendorfer-Rutz E, Taipale H, Rahman S, Niederkrotenthaler T, Klimek P. Association of medication clusters and subsequent labor market marginalization in refugee and Swedish-born young adults with common mental disorders in Sweden. Eur
Child Adolesc Psychiatry 2024:33(3):897-907.
|
|
65 |
Chen L, Mittendorfer-Rutz E, Björkenstam E, Rahman S, Gustafsson K, Kjeldgård L, Ekselius L, Taipale H, Tanskanen A, Helgesson M. Labour market integration among young adults diagnosed with attention-deficit/hyperactivity disorder (ADHD) at working
age. Psychol Med 2024:54(1):148-158.
|
|
66 |
de Montgomery C, Cullen A, Taipale H, Krasnik A, Norredam M, Mittendorfer-Rutz E. Incidence of non-affective psychotic disorders in refugees and peers growing up in Denmark and Sweden. Soc Psychiatry Psychiatr Epidemiol
2024:59(7):1153-1165.
|
|
67 |
de Montgomery DJ, Faurholdt IM, Cullen AE, Taipale H, Mittendorfer-Rutz E, Krasnik A, Norredam M. Involuntary admissions for non-affective psychotic disorders in young refugees and peers in Denmark: A population cohort study. Schizophr Res
2024(270):366-371.
|
|
68 |
Denissoff A, Taipale H, Tiihonen J, Di Forti M, Mittendorfer-Rutz E, Tanskanen A, Mustonen A, Niemelä S. Antipsychotic Use and Psychiatric Hospitalization in First-Episode Non-affective Psychosis and Cannabis Use Disorder: A Swedish Nationwide Cohort
Study. Schizophr Bull 2024:50(6):1287-1294.
|
|
69 |
Efthimiou O, Taipale H, Radua J, Schneider-Thoma J, Pinzón-Espinosa J, Ortuńo M, Vinkers CH, Mittendorfer-Rutz E, Cardoner N, Tanskanen A, Fusar-Poli P, Cipriani A, Vieta E, Leucht S, Tiihonen J, Luykx JJ. Efficacy and effectiveness of antipsychotics
in schizophrenia: network meta-analyses combining evidence from randomised controlled trials and real-world data. Lancet Psychiatry 2024:11(2):102-111.
|
|
70 |
Fabiano N, Gupta A, Wong S, Tran J, Mohammad IYz, Bal S, Fiedorowicz JG, Firth J, Stubbs B, Vancampfort D, Schuch FB, Carr LJ, Shorr R, Cortese S, Manchia M, Hartman CA, Hųye A, Fusar-Poli P, Koyanagi A, ..., Taipale H, et al. Physical activity,
suicidal ideation, suicide attempt and death among individuals with mental or other medical disorders: A systematic review of observational studies. Neurosci Biobehav Rev 2024:158:105547.
|
|
71 |
Hamina A, Odsbu I, Hjellvik V, Lid TG, Clausen T, Skurtveit S. Fatal drug overdoses in individuals treated pharmacologically for chronic pain: a nationwide register-based study. Br J Anaesth 2024:132(1):86-95.
|
|
72 |
Hamina A, Taipale H, Lieslehto J, Lähteenvuo M, Tanskanen A, Mittendorfer-Rutz E, Tiihonen J. Comparative Effectiveness of Antipsychotics in Patients With Schizophrenia Spectrum Disorder. JAMA Netw Open 2024:7(10):e2438358.
|
|
73 |
Helgesson M, Pettersson E, Lindsäter E, Taipale H, Tanskanen A, Mittendorfer-Rutz E, Cullen AE. Trajectories of work disability among individuals with anxiety-, mood/affective-, or stress-related disorders in a primary healthcare setting. BMC
Psychiatry 2024:24(1):623.
|
|
74 |
Holm M, Tanskanen A, Tiihonen J, Taipale H. Medication use and sickness absence from work in bipolar disorder: a nationwide register-based study. World Psychiatry 2024:23(2):296-298.
|
|
75 |
Jeyapalan J, Sassi P, Mittendorfer Rutz E, Tiihonen J, Taipale H, Niemelä S. Characteristics of incident substance-induced psychosis compared to first-episode psychotic disorders: A nationwide register-linkage study from Sweden. Schizophr Res
2024:264:526-533.
|
|
76 |
Koch E, Kämpe A, Alver M, Siguršarson S, Einarsson G, Partanen J, Smith RL, Jaholkowski P, Taipale H, Lähteenvuo M, Steen NEiel, Smeland OB, Djurovic S, Molden E, Molden E, Molden E, Sigurdsson E, Stefįnsson H, Stefįnsson K, Palotie A, et al.
Polygenic liability for antipsychotic dosage and polypharmacy - a real-world registry and biobank study. Neuropsychopharmacology 2024:49(7):1113-1119.
|
|
77 |
Konttajärvi T, Haapea M, Huhtaniska S, Björnholm L, Miettunen J, Isohanni M, Penttilä M, Murray GK, Koponen H, Vernon AC, Jääskeläinen E, Lieslehto J. The contribution of first-episode illness characteristics and cumulative antipsychotic usage to
progressive structural brain changes over a long-term follow-up in schizophrenia. Psychiatry Res 2024:339:111790.
|
|
78 |
Koskuvi M, Pörsti E, Hewitt T, Räsänen N, Wu Y, Trontti K, McQuade A, Kalyanaraman S, Ojansuu I, Vaurio O, Cannon TD, Lönnqvist J, Therman S, Suvisaari J, Kaprio J, Blurton-Jones M, Hovatta I, Lähteenvuo M, ..., Tiihonen J, et al. Genetic
contribution to microglial activation in schizophrenia. Mol Psychiatry 2024:29(9):2622-2633.
|
|
79 |
Kostovski E, Hamina A, Hjellvik V, Clausen T, Skurtveit S. Increased cancer incidence and mortality among people with opioid use-related disorders: A nation-wide cohort study. Addiction 2024:119(9):1575-1584.
|
|
80 |
Kämpe A, Suvisaari J, Lähteenvuo M, Singh T, Ahola-Olli A, Urpa L, Haaki W, Hietala J, Isometsä E, Jukuri T, Kampman O, Kieseppä T, Lahdensuo K, Lönnqvist J, Männynsalo T, Paunio T, Niemi-Pynttäri J, Suokas K, Tuulio-Henriksson A, Veijola J, et al.
Genetic contribution to disease-course severity and progression in the SUPER-Finland study, a cohort of 10,403 individuals with psychotic disorders. Mol Psychiatry 2024:29(9):2733-2741.
|
|
81 |
Lampela P, Tanskanen A, Lähteenvuo M, Tiihonen J, Taipale H. Effect of severity of depression on augmentation of antidepressant medication in young adults with depression. Acta Psychiatr Scand 2024:149(1):41-51.
|
|
82 |
Lieslehto J, Tiihonen J, Lähteenvuo M, Leucht S, Correll CU, Mittendorfer-Rutz E, Tanskanen A, Taipale H. Development and Validation of a Machine Learning-Based Model of Mortality Risk in First-Episode Psychosis. JAMA Netw Open
2024:7(3):e240640.
|
|
83 |
Lochmann van Bennekom M, IntHout J, Gijsman HJ, Akdede BB, Yagcioglu AE, Barnes TR, Galling B, ..., Repo-Tiihonen E, et al. Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and
meta-analysis of individual patient data. Schizophr Res 2024:272:1-11.
|
|
84 |
Lukkarinen L, Tuisku J, Sun L, Helin S, Karlsson HK, Venetjoki N, Salomaa M, Rautio P, Hirvonen J, Lauerma H, Tiihonen J, Nummenmaa L. Aberrant type 2 dopamine receptor availability in violent offenders with psychopathy. Neuroimage
2024:297:120724.
|
|
85 |
Lumén K, Louheranta O, Kuosmanen L. Forensic Psychiatric Patients' Experiences of Personal Recovery: A Wilsonian Concept Analysis. J Forensic Nurs 2024:20(2):103-112.
|
|
86 |
Lumén K, Louheranta O, Kuosmanen L. A narrative of recovery in forensic hospitals. Arch Psychiatr Nurs 2024:51:120-126.
|
|
87 |
Luykx JJ, Correll CU, Manu P, Tanskanen A, Hasan A, Tiihonen J, Taipale H. Pneumonia Risk, Antipsychotic Dosing, and Anticholinergic Burden in Schizophrenia. JAMA Psychiatry 2024:81(10):967-975.
|
|
88 |
Luykx JJ, Tanskanen A, Lähteenvuo M, Manu P, Correll CU, Hasan A, Lieslehto J, Taipale H, Tiihonen J. Dopamine D2 receptor antagonism of antipsychotics and the risk of death due to choking. Psychiatry Res 2024:339:116012.
|
|
89 |
Luykx JJ, Tiihonen J, Taipale H. Antipsychotic Monotherapy vs Polytherapy for Pneumonia Risk-Reply. JAMA Psychiatry 2024:81(12):1278-1279.
|
|
90 |
Mastafa S, Montgomery C, Pettersson E, Norredam M, Krasnik A, Taipale H, Mittendorfer-Rutz E, Cullen A. Risk of unemployment and work disability among refugee and non-refugee migrants with incident psychotic disorders in Sweden and Denmark. Eur J
Public Health 2024:34(1):129-135.
|
|
91 |
Mittendorfer-Rutz E, Bergström J, Josefsson P, Taipale H, Sijbrandij M, Witteveen A, Monzio Compagnoni M, Lora A, Felez-Nobrega M, Haro J, et al. Suicidal behavior in patients with severe mental disorders prior to and during the COVID-19 pandemic.
Psychol Med 2024:54(16):4759-4767.
|
|
92 |
Mäkipelto V, Tuulio-Henriksson A, Hakulinen C, Niemelä S, Lähteenvuo M, Wegelius A, Kieseppä T, Isometsä E, Tiihonen J, Kampman O, Lahdensuo K, Mazumder A, Suvisaari J, Holm M. Association of antidepressant and benzodiazepine use, and anticholinergic
burden with cognitive performance in schizophrenia. Schizophr Res 2024:266:118-126.
|
|
93 |
Nestvold HH, Skurtveit SS, Hamina A, Hjellvik V, Odsbu I. Socioeconomic risk factors for long-term opioid use: A national registry-linkage study. Eur J Pain 2024:28(1):95-104.
|
|
94 |
Ojansuu I, Forsman J, Kautiainen H, Seppänen A, Tiihonen J, Lähteenvuo M. Association of duration of treatment on post-discharge mortality in forensic psychiatric patients in Finland. Front Psychiatry 2024:15:1372687.
|
|
95 |
Paljärvi T, Herttua K, Taipale H, Lähteenvuo M, Tanskanen A, Tiihonen J. Cardiovascular mortality in bipolar disorder: Population-based cohort study. Acta Psychiatr Scand 2024:150(2):56-64.
|
|
96 |
Paljärvi T, McPherson T, Thompson C, Luciano S, Herttua K, Fazel S. Neuropsychiatric diagnoses after isotretinoin initiation in pediatric acne patients: A retrospective cohort study. J Am Acad Dermatol 2024:91(3):571-573.
|
|
97 |
Partanen JJ, Häppölä P, Kämpe A, Ahola-Olli A, Hellsten A, Rask SM, Haaki W, Hietala J, Kampman O, Tiihonen J, Tanskanen AJ, Daly MJ, Ripatti S, Palotie A, Taipale H, Lähteenvuo M, Koskela JT. High Burden of Ileus and Pneumonia in Clozapine-Treated
Individuals With Schizophrenia: A Finnish 25-Year Follow-Up Register Study. Am J Psychiatry 2024:181(10):879-892.
|
|
98 |
Rubio JM, Kane JM, Tanskanen A, Tiihonen J, Taipale H. Long-term persistence of the risk of agranulocytosis with clozapine compared with other antipsychotics: a nationwide cohort and case-control study in Finland. Lancet Psychiatry
2024:11(6):443-450.
|
|
99 |
Räsänen N, Tiihonen J, Koskuvi M, Lehtonen S, Jalkanen N, Karmila N, Weert I, Vaurio O, Ojansuu I, Lähteenvuo M, Pietiläinen O, Koistinaho J. Astrocytes Regulate Neuronal Network Burst Frequency Through NMDA Receptors in a Species- and Donor-Specific
Manner. Biol Psychiatry Glob Open Sci 2024:4(4):100313.
|
|
100 |
Solmi M, Croatto G, Fornaro M, Schneider LK, Rohani-Montez SC, Fairley L, Smith N, Bitter I, Gorwood P, Taipale H, Tiihonen J, Cortese S, Dragioti E, Rietz E, Nielsen RE, Firth J, Fusar-Poli P, Hartman C, Holt RI, Hųye A, et al. Regional differences
in mortality risk and in attenuating or aggravating factors in schizophrenia: A systematic review and meta-analysis. Eur Neuropsychopharmacology 2024:80:55-69.
|
|
101 |
Solmi M, Croatto G, Gupta A, Fabiano N, Wong S, Fornaro M, Schneider LK, Rohani-Montez SC, Fairley L, Smith N, Bitter I, Gorwood P, Taipale H, Tiihonen J, Cortese S, Dragioti E, Rietz ED, Nielsen RE, Firth J, Fusar-Poli P, et al. Effects of
antipsychotic treatment on cardio-cerebrovascular related mortality in schizophrenia: A subanalysis of a systematic review and meta-analysis with meta-regression of moderators. Eur Neuropsychopharmacology 2024:88:6-20.
|
|
102 |
Solmi M, Lähteenvuo M, Tanskanen A, Corbeil O, Mittendorfer-Rutz E, Correll CU, Tiihonen J, Taipale H. Antipsychotic Use and Risk of Breast Cancer in Women With Severe Mental Illness: Replication of a Nationwide Nested Case-Control Database Study.
Schizophr Bull 2024:50(6):1471-1481.
|
|
103 |
Solmi M, Miola A, Capone F, Pallottino S, Hųjlund M, Firth J, Siskind D, Holt RI, Corbeil O, Cortese S, Dragioti E, Du Rietz E, Nielsen RE, Nordentoft M, Fusar-Poli P, Hartman CA, Hųye A, ..., Taipale H, et al. Risk factors, prevention and treatment
of weight gain associated with the use of antidepressants and antipsychotics: a state-of-the-art clinical review. Expert Opin Drug Saf 2024:23(10):1249-1269.
|
|
104 |
Solmi M, Thompson T, Estradé A, Agorastos A, Radua J, Cortese S, Dragioti E, Vancampfort D, Thygesen LC, Aschauer H, Schlögelhofer M, Aschauer E, Schneeberger A, Huber CG, Hasler G, Conus P, Cuénod KQ, von Känel R, Tiihonen J, et al. Global and
risk-group stratified well-being and mental health during the COVID-19 pandemic in adults: Results from the international COH-FIT Study. Psychiatry Res 2024:342:115972.
|
|
105 |
Spathopoulou A, Sauerwein GA, Marteau V, Podlesnic M, Lindlbauer T, Kipura T, Hotze M, Gabassi E, Kruszewski K, Koskuvi M, Réthelyi JM, Apįti Į, Conti L, Ku M, Koal T, Müller U, Talmazan RA, Ojansuu I, Vaurio O, Lähteenvuo M, Tiihonen J, et al.
Integrative metabolomics-genomics analysis identifies key networks in a stem cell-based model of schizophrenia. Mol Psychiatry 2024:29(10):3128-3140.
|
|
106 |
Särkilä H, Taipale H, Tanskanen A, Kurko T, Taiminen T, Tiihonen J, Sund R, Saastamoinen L, Hietala J, Niemelä S. Characteristics of high-dose benzodiazepine use: nationwide cohort study on new benzodiazepine users with 5-year follow-up. BJPsych
Open 2024:10(5):e158.
|
|
107 |
Taipale H, Bergström J, Gčmes K, Tanskanen A, Ekselius L, Mittendorfer-Rutz E, Helgesson M. Attention-Deficit/Hyperactivity Disorder Medications and Work Disability and Mental Health Outcomes. JAMA Netw Open 2024:7(3):e242859.
|
|
108 |
Taipale H, Lieslehto J, Lähteenvuo M, Hamina A, Tanskanen A, Mittendorfer-Rutz E, Paljärvi T, Solmi M, Cipriani A, Correll CU, Tiihonen J. Real-world effectiveness of antidepressants, antipsychotics and their combinations in the maintenance treatment
of psychotic depression. Evidence from within-subject analyses of two nationwide cohorts. World Psychiatry 2024:23(2):276-284.
|
|
109 |
Taipale H, Solmi M, Correll CU, Tiihonen J. Relative Risk of Breast Cancer Associated With Prolactin-Increasing Antipsychotic Use. J Clin Psychiatry 2024:85(1):23lr15135.
|
|
110 |
Taipale H, Tanskanen A, Kurko T, Taiminen T, Särkilä H, Tiihonen J, Sund R, Niemelä S, Saastamoinen L, Hietala J. Long-term benzodiazepine use and risk of labor market marginalization in Finland: A cohort study with 5-year follow-up. Eur
Psychiatry 2024:67(1):e34.
|
|
111 |
Tiihonen J, Taipale H. The challenges of antipsychotic polypharmacy. Lancet Psychiatry 2024:11(12):945-946.
|
|
112 |
Toimela JS, Halt AH, Kerkelä M, Kampman O, Suvisaari J, Kieseppä T, Lähteenvuo M, Tiihonen J, Ahola-Olli A, Veijola J, Holm M, Holm M. Association of obesity to reaction time and visual memory in schizophrenia. Schizophr Res Cogn
2024:37:100316.
|
|
113 |
Tuppurainen H, Määttä S, Könönen M, Julkunen P, Kautiainen H, Hyvärinen S, Vaurio O, Joensuu M, Vanhanen M, Aho-Mustonen K, Mervaala E, Tiihonen J. Navigated and individual [alpha]-peak-frequency-guided transcranial magnetic stimulation in male
patients with treatment-refractory schizophrenia. J Psychiatry Neurosci 2024:49(2):E87-E95.
|
|
114 |
Vinkers CH, Kupka RW, Penninx BW, Ruhé HG, van Gaalen JM, van Haaren PC, Schellekens AF, Jauhar S, Ramos-Quiroga JA, Vieta E, Tiihonen J, Veldman SE, Veling W, Vis R, de Wit LE, Luykx JJ. Discontinuation of psychotropic medication: a synthesis of
evidence across medication classes. Mol Psychiatry 2024:29(8):2575-2586.
|
|
115 |
Asikainen J, Vehviläinen-Julkunen K, Repo-Tiihonen E, Louheranta O. Use of debriefing following restrictive practices in forensic psychiatric care. J Forensic Pract 2023:25(1):46-56.
|
|
116 |
Asikainen J, Vehviläinen-Julkunen K, Repo-Tiihonen E, Louheranta O. Patients' Perceptions of Safety and Debriefing in Forensic Mental Health Care in Finland. J Forensic Nurs 2023:19(3):187-196.
|
|
117 |
Borger Rognli E, Taipale H, Hjorthųj C, Mittendorfer-Rutz E, Bramness JG, Heiberg IH, Niemelä S. Annual incidence of substance-induced psychoses in Scandinavia from 2000 to 2016. Psychol Med 2023:53(11):5246-5255.
|
|
118 |
Cederlöf E, Holm M, Ahti J, Lähteenvuo M, Hietala J, Häkkinen K, Isometsä E, Kampman O, Lahdensuo K, Lönnqvist J, Suvisaari J, Tiihonen J, Wegelius A, Veijola J, Palotie A, Kieseppä T, Niemelä S, Paunio T. Substance use and sleep problems in patients
with psychotic disorders. Schizophr Bull Open 2023:4(1):sgac073.
|
|
119 |
Cullen AE, de Montgomery CJ, Norredam M, Bergström J, Krasnik A, Taipale H, Mittendorfer-Rutz E. Comparison of Hospitalization for Nonaffective Psychotic Disorders Among Refugee, Migrant, and Native-Born Adults in Sweden and Denmark. JAMA Netw
Open 2023:6(10):e2336848.
|
|
120 |
Cullen AE, Lindsäter E, Rahman S, Taipale H, Tanskanen A, Mittendorfer-Rutz E, Helgesson M. Patient factors associated with receipt of psychological and pharmacological treatments among individuals with common mental disorders in a Swedish primary
care setting. BJPsych Open 2023:9(2):e40.
|
|
121 |
Fiorito AM, Aleman A, Blasi G, Bourque J, Cao H, Chan RC, Chowdury A, Conrod P, Diwadkar VA, Goghari VM, Guinjoan S, Gur RE, Gur RC, Kwon JS, Lieslehto J, Lukow PB, Meyer-Lindenberg A, Modinos G, Quarto T, Spilka MJ, et al. Are Brain Responses to
Emotion a Reliable Endophenotype of Schizophrenia? An Image-Based Functional Magnetic Resonance Imaging Meta-analysis. Biol Psychiatry 2023:93(2):167-177.
|
|
122 |
Gémes K, Taipale H, Björkenstam E, Rahman S, Gustafsson K, Tanskanen A, Ekselius L, Mittendorfer-Rutz E, Helgesson M. The role of sociodemographic and clinical factors in the initiation and discontinuation of attention deficit hyperactivity disorder
medication among young adults in Sweden. Front Psychiatry 2023:14:1152286.
|
|
123 |
Hamina A, Paljärvi T, Tanskanen A, Lähteenvuo M, Tiihonen J, Taipale H. Use of antipsychotics and antidepressants in first-episode psychotic depression: A nationwide register-based study. Acta Psychiatr Scand 2023:148(5):416-425.
|
|
124 |
Heikkinen M, Taipale H, Tanskanen A, Mittendorfer-Rutz E, Lähteenvuo M, Tiihonen J. Association of Pharmacological Treatments and Hospitalization and Death in Individuals With Amphetamine Use Disorders in a Swedish Nationwide Cohort of 13 965
Patients. JAMA Psychiatry 2023:80(1):31-39.
|
|
125 |
Helgesson M, Björkenstam E, Rahman S, Gustafsson K, Taipale H, Tanskanen A, Ekselius L, Mittendorfer-Rutz E. Labour market marginalisation in young adults diagnosed with attention-deficit hyperactivity disorder (ADHD): a population-based longitudinal
cohort study in Sweden. Psychol Med 2023:53(4):1224-1232.
|
|
126 |
Helgesson M, Kjeldgård L, Björkenstam E, Rahman S, Gustafsson K, Taipale H, Tanskanen A, Ekselius L, Mittendorfer-Rutz E. Sustainable labour market participation among working young adults with diagnosed attention deficit/hyperactivity disorder
(ADHD). SSM Popul Health 2023:23:101444.
|
|
127 |
Herttua K, Thapa S, Juel Ahrenfeldt L, Paljarvi T. The role of modifiable risk factors in incident cancer in transport, rescue, and security industries. Ann Epidemiol 2023:83:71-77.e1.
|
|
128 |
Hodgins S, Eronen M, Freese R, Hart S, Mueller-Isberner R, Ross D, Webster C, Tiihonen J. Correspondence regarding De Girolamo et al., 2021 'A multinational case-control study comparing forensic and non-forensic patients with schizophrenia spectrum
disorders: the EU-VIORMED project'. Psychol Med 2023:53(8):3764-3765.
|
|
129 |
Holopainen R, Tiihonen J, Lähteenvuo M. Efficacy of immersive extended reality (XR) interventions on different symptom domains of schizophrenia spectrum disorders. A systematic review. Front Psychiatry 2023:14:1208287.
|
|
130 |
Häkkinen K, Kiander W, Kidron H, Lähteenvuo M, Urpa L, Lintunen J, Vellonen K, Auriola S, Holm M, Lahdensuo K, Kampman O, Isometsä E, Kieseppä T, Lönnqvist J, Suvisaari J, Hietala J, Tiihonen J, Palotie A, Ahola-Olli AV, Niemi M. Functional
Characterization of Six SLCO1B1 (OATP1B1) Variants Observed in Finnish Individuals with a Psychotic Disorder. Mol Pharm 2023:20(3):1500-1508.
|
|
131 |
Juntunen A, Määttä S, Könönen M, Kallioniemi E, Niskanen E, Kaarre O, Kivimäki P, Vanninen R, Tolmunen T, Ferreri F, Kekkonen V. Cortical thickness is inversely associated with transcranial magnetic stimulation-evoked N45 potential among young adults
whose heavy drinking began in adolescence. Alcohol Clin Exp Res (Hoboken) 2023:47(7):1341-1351.
|
|
132 |
Kekkonen V, Kraav S-L, Hintikka J, Kivimäki P, Kaarre O, Tolmunen T. Externally oriented thinking style increases primary health care use in adolescence. Eur J Public Health 2023:33(3):418-423.
|
|
133 |
Koistinaho A, Poranen J, Tanskanen A, Tiihonen J, Taipale H, Lähteenvuo M. Real-world use of pharmacological treatments for incident bipolar disorder: A Finnish nationwide cohort study. J Affect Disord 2023:340:237-244.
|
|
134 |
Lehti V, Salama E, Niemelä S, Tanskanen A, Gissler M, Suvisaari J, Taipale H. Use of benzodiazepine and related drugs in migrants and Finnish-born persons: a nationwide register-based study. Scand J Public Health 2023:51(8):1222-1230.
|
|
135 |
Lehti V, Taipale H, Gissler M, Tanskanen A, Elonheimo M, Tiihonen J, Suvisaari J. Continuity of antipsychotic medication use among migrant and Finnish-born populations with a psychotic disorder: a register-based study. Psychol Med
2023:53(3):833-843.
|
|
136 |
Lieslehto J, Tiihonen J, Lähteenvuo M, Mittendorfer-Rutz E, Tanskanen A, Taipale H. Comparative Effectiveness of Pharmacotherapies for the Risk of Attempted or Completed Suicide Among Persons With Borderline Personality Disorder. JAMA Netw
Open 2023:6(6):e2317130.
|
|
137 |
Lieslehto J, Tiihonen J, Lähteenvuo M, Mittendorfer-Rutz E, Tanskanen A, Taipale H. Association of pharmacological treatments and real-world outcomes in borderline personality disorder. Acta Psychiatr Scand 2023:147(6):603-613.
|
|
138 |
Lintunen J, Lähteenvuo M, Tanskanen A, Tiihonen J, Taipale H. Non-adherence to mood stabilizers and antipsychotics among persons with bipolar disorder - A nationwide cohort study. J Affect Disord 2023:333:403-408.
|
|
139 |
Lundberg J, Cars T, Lööv S, Söderling J, Sundström J, Tiihonen J, Leval A, Gannedahl A, Björkholm C, Själin M, Hellner C. Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide
Study. JAMA Psychiatry 2023:80(2):167-175.
|
|
140 |
Luykx JJ, Gonzalez-Diaz JM, Guu T, van der Horst MZ, van Dellen E, Boks MP, Guloksuz S, DeLisi LE, Sommer IE, Cummins R, Shiers D, Lee J, Every-Palmer S, Mhalla A, Chadly Z, Chan SK, Cotes RO, Takahashi S, Benros ME, Wagner E, ..., Tiihonen J, et al.
An international research agenda for clozapine-resistant schizophrenia. Lancet Psychiatry 2023:10(8):644-652.
|
|
141 |
Lähteenvuo M, Ahola-Olli A, Suokas K, Holm M, Misiewicz Z, Jukuri T, Männynsalo T, Wegelius A, Haaki W, Kajanne R, Kyttälä A, Tuulio-Henriksson A, Lahdensuo K, Häkkinen K, Hietala J, Paunio T, Niemi-Pynttäri J, Kieseppä T, ..., Tiihonen J, et al.
Cohort profile: SUPER-Finland - the Finnish study for hereditary mechanisms of psychotic disorders. BMJ Open 2023:13(4):e070710.
|
|
142 |
Lähteenvuo M, Paljärvi T, Tanskanen A, Taipale H, Tiihonen J. Real-world effectiveness of pharmacological treatments for bipolar disorder: register-based national cohort study. Br J Psychiatry 2023:223(4):456-464.
|
|
143 |
Ojansuu I, Latvala A, Kautiainen H, Forsman J, Tiihonen J, Lähteenvuo M. General and violent recidivism of former forensic psychiatric patients in Finland. Front Psychiatry 2023:14:1157171.
|
|
144 |
Paakinaho A, Tiihonen M, Koskela H, Koponen M, Tiihonen J , Hartikainen S, Tolppainen A-M. ß2-Adrenoceptor Agonists in Asthma or Chronic Obstructive Pulmonary Disease and Risk of Parkinson's Disease: Nested Case-Control Study. Clin Epidemiol
2023:15:695-705.
|
|
145 |
Paljärvi T, Herttua K, Taipale H, Lähteenvuo M, Tanskanen A, Fazel S, Tiihonen J. Cause-specific excess mortality after first diagnosis of bipolar disorder: population-based cohort study. BMJ Ment Health 2023:26(1):e300700.
|
|
146 |
Paljärvi T, Tiihonen J, Lähteenvuo M, Tanskanen A, Fazel S, Taipale H. Mortality in psychotic depression: 18-year follow-up study. Br J Psychiatry 2023:222(1):37-43.
|
|
147 |
Paljärvi T, Tiihonen J, Lähteenvuo M, Tanskanen A, Fazel S, Taipale H. Psychotic depression and deaths due to suicide. J Affect Disord 2023:321:28-32.
|
|
148 |
Popovic D, Wertz M, Geisler C, Kaufmann J, Lähteenvuo M, Lieslehto J, Witzel J, Bogerts B, Walter M, Falkai P, Koutsouleris N, Schiltz K. Patterns of risk-Using machine learning and structural neuroimaging to identify pedophilic offenders. Front
Psychiatry 2023:14:1001085.
|
|
149 |
Puranen A, Koponen M, Lähteenvuo M, Tanskanen A, Tiihonen J, Taipale H. Real-world effectiveness of antidepressant use in persons with schizophrenia: within-individual study of 61,889 subjects. Schizophrenia (Heidelb) 2023:9(1):34.
|
|
150 |
Puranen A, Koponen M, Lähteenvuo M, Tanskanen A, Tiihonen J, Taipale H. Real-world effectiveness of mood stabilizer use in schizophrenia. Acta Psychiatr Scand 2023:147(3):257-266.
|
|
151 |
Rahkonen A, Taipale H, Koponen M, Hartikainen S, Tolppanen A, Tanskanen A, Tiihonen M. The Cumulative Use of Muscle Relaxants and the Risk of Alzheimer's Disease: A Nationwide Case-Control Study. J Alzheimers Dis 2023:91(4):1283-1290.
|
|
152 |
Solmi M, Lähteenvuo M, Correll CU, Tanskanen A, Tiihonen J, Taipale H. Antipsychotic Use and Risk of Low-Energy Fractures in People With Schizophrenia: A Nationwide Nested Case-Control Study in Finland. Schizophr Bull 2023:49(1):78-89.
|
|
153 |
Solmi M, Thompson T, Estrade A, ..., Tiihonen J, et al. Validation of the Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) questionnaire for adults. J Affect Disord 2023:326:249-261.
|
|
154 |
Sommer IE, Brand BA, Gangadin S, Tanskanen A, Tiihonen J, Taipale H. Women with Schizophrenia-Spectrum Disorders After Menopause: A Vulnerable Group for Relapse. Schizophr Bull 2023:49(1):136-143.
|
|
155 |
Spaton Goppers J, Mittendorfer-Rutz E, Cullen AE, Jamil de Montgomery C, Tanskanen A, Norredam M, Taipale H. Antipsychotic treatment patterns in refugees and their Swedish-born peers with first-episode non-affective psychosis: findings from the
REMAIN study. BJPsych Open 2023:9(3):e57.
|
|
156 |
Taipale H, Tanskanen A, Tiihonen J. Safety of Antipsychotic Polypharmacy Versus Monotherapy in a Nationwide Cohort of 61,889 Patients With Schizophrenia. Am J Psychiatry 2023:180(5):377-385.
|
|
157 |
Taipale M, Tiihonen J, Korhonen J, Popovic D, Vaurio O, Lähteenvuo M, Lieslehto J. Effects of Substance Use and Antisocial Personality on Neuroimaging-Based Machine Learning Prediction of Schizophrenia. Schizophr Bull
2023:49(6):1568-1578.
|
|
158 |
Tiihonen J. The use of long-acting injectables in early-phase schizophrenia. Lancet Psychiatry 2023:10(7):481-482.
|
|
159 |
van der Horst MZ, Meijer Y, de Boer N, Guloksuz S, Hasan A, Siskind D, Wagner E, ..., Hallikainen T, et al. Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions.
Psychiatry Res 2023:330:115539.
|
|
160 |
Ahti J, Kieseppä T, Suvisaari J, Suokas K, Holm M, Wegelius A, Ahola-Olli A, Häkkinen K, Kampman O, Lähteenvuo M, Paunio T, Tiihonen J, Tuulio-Henriksson A, Isometsä E. Differences in psychosocial functioning between psychotic disorders in the
Finnish SUPER study. Schizophr Res 2022:244:10-17.
|
|
161 |
Askola R, Louheranta O, Seppänen A. Factors Affecting Treatment Regress and Progress in Forensic Psychiatry: A Thematic Analysis. Front Psychiatry 2022:13:884410.
|
|
162 |
Babar BA, Vu M, Koponen M, Taipale H, Tanskanen A, Kettunen R, Tiihonen M, Hartikainen S, Tolppanen A. Prevalence of oral anticoagulant use among people with and without Alzheimer's disease. BMC Geriatr 2022:22(1):464.
|
|
163 |
Cederlöf E, Holm M, Lähteenvuo M, Haaki W, Hietala J, Häkkinen K, Isometsä E, Jukuri T, Kajanne R, Kampman O, Kieseppä T, Lahdensuo K, Lönnqvist J, Männynsalo T, Niemi-Pynttäri J, Suokas K, Suvisaari J, Tiihonen J, Turunen H, et al. Sleep in
psychotic disorders: Results from nationwide SUPER Finland study. Schizophr Bull 2022:3(1):sgac011.
|
|
164 |
Chen L, Mittendorfer-Rutz E, Björkenstam E, Rahman S, Gustafsson K, Taipale H, Tanskanen A, Ekselius L, Helgesson M. Risk Factors for Disability Pension among Young Adults Diagnosed with Attention-deficit Hyperactivity Disorder (ADHD) in Adulthood.
J Atten Disord 2022:26(5):723-734.
|
|
165 |
Correll CU, Bitter I, Hoti F, Mehtälä J, Wooller A, Pungor K, Tiihonen J. Factors and their weight in reducing life expectancy in schizophrenia. Schizophr Res 2022:250:67-75.
|
|
166 |
Correll CU, Solmi M, Croatto G, Kolton Schneider L, Rohani-Montez SC, Fairley L, Smith N, Bitter I, Gorwood P, Taipale H, Tiihonen J. Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or
attenuating factors. World Psychiatry 2022:21(2):248-271.
|
|
167 |
Fazel S, Paljarvi T. Response to 'Isotretinoin and adverse neuropsychiatric outcomes: retrospective cohort study using routine data': reply from authors. Br J Dermatol 2022:187(3):450-451.
|
|
168 |
Gémes K, Björkenstam E, Rahman S, Gustafsson K, Taipale H, Tanskanen A, Ekselius L, Mittendorfer-Rutz E, Helgesson M. Occupational Branch and Labor Market Marginalization among Young Employees with Adult Onset of Attention Deficit Hyperactivity
Disorder-A Population-Based Matched Cohort Study. Int J Environ Res Public Health 2022:19(12):7254.
|
|
169 |
Hamina A, Muller AE, Clausen T, Skurtveit S, Hesse M, Tjagvad C, Thylstrup B, Odsbu I, Zoega H, Jónsdóttir HL, Taipale H. Prescription opioids among older adults: ten years of data across five countries. BMC Geriatr 2022:22(1):429.
|
|
170 |
Heikkinen M, Taipale H, Tanskanen A, Mittendorfer-Rutz E, Lähteenvuo M, Tiihonen J. Real-world effectiveness of pharmacological treatments of opioid use disorder in a national cohort. Addiction 2022:117(6):1683-1691.
|
|
171 |
Herttua K, Crawford M, Paljarvi T, Fazel S. Associations between antipsychotics and risk of violent crimes and suicidal behaviour in personality disorder. Evid Based Ment Health 2022:25(e1):e58-e64.
|
|
172 |
Holm M, Tanskanen A, Lähteenvuo M, Tiihonen J, Taipale H. Comparative effectiveness of mood stabilizers and antipsychotics in the prevention of hospitalization after lithium discontinuation in bipolar disorder. Eur Neuropsychopharmacology
2022:61:36-42.
|
|
173 |
Häkkinen K, Kiiski JI, Lähteenvuo M, Jukuri T, Suokas K, Niemi-Pynttäri J, Kieseppä T, Männynsalo T, Wegelius A, Haaki W, Lahdensuo K, Kajanne R, Kaunisto MA, Tuulio-Henriksson A, Kampman O, Hietala J, Veijola J, ..., Tiihonen J, et al.
Implementation of CYP2D6 copy-number imputation panel and frequency of key pharmacogenetic variants in Finnish individuals with a psychotic disorder. Pharmacogenomics J 2022:22(3):166-172.
|
|
174 |
Kieseppä V, Markkula N, Taipale H, Holm M, Jokela M, Suvisaari J, Tanskanen A, Gissler M, Lehti V. Antidepressant use among immigrants with depressive disorder living in Finland: A register-based study. J Affect Disord 2022:299:528-535.
|
|
175 |
Koponen M, Rajamaki B, Lavikainen P, Bell JS, Taipale H, Tanskanen A, Hartikainen S, Tolppanen A. Antipsychotic Use and Risk of Stroke Among Community-Dwelling People With Alzheimer's Disease. J Am Med Dir Assoc 2022:23(6):1059-1065.e4.
|
|
176 |
Koskuvi M, Lehtonen S, Trontti K, Keuters M, Wu Y, Koivisto H, Ludwig A, Plotnikova L, Virtanen PL, Räsänen N, Kaipainen S, Hyötyläinen I, Dhungana H, Giniatullina R, Ojansuu I, Vaurio O, ..., Lähteenvuo M, ..., Tiihonen J, et al. Contribution of
astrocytes to familial risk and clinical manifestation of schizophrenia. Glia 2022:70(4):650-660.
|
|
177 |
Kuosmanen A, Tiihonen J, Repo-Tiihonen E, Turunen H. Voluntary patient safety incidents reporting in forensic psychiatry-What do the reports tell us? J Psychiatr Mental Health Nurs 2022:29(1):36-47.
|
|
178 |
Lieslehto J, Rantanen N, Oksanen LA, Oksanen SA, Kivimäki A, Paju S, Pietiäinen M, Lahdentausta L, Pussinen P, Anttila V, Lehtonen L, Lallukka T, Geneid A, Sanmark E. A machine learning approach to predict resilience and sickness absence in the
healthcare workforce during the COVID-19 pandemic. Sci Rep 2022:12(1):8055.
|
|
179 |
Lieslehto J, Tiihonen J, Lähteenvuo M, Tanskanen A, Taipale H. Primary Nonadherence to Antipsychotic Treatment Among Persons with Schizophrenia. Schizophr Bull 2022:48(3):655-663.
|
|
180 |
Lintunen J, Lähteenvuo M, Tanskanen A, Tiihonen J, Taipale H. Allopurinol, dipyridamole and calcium channel blockers in the treatment of bipolar disorder - A nationwide cohort study. J Affect Disord 2022:313:43-48.
|
|
181 |
Lundberg J, Cars T, Lööv S-Å, Söderling J, Tiihonen J, Leval A, Gannedahl A, Björkholm C, Själin M, Hellner C. Clinical and societal burden of incident major depressive disorder: A population-wide cohort study in Stockholm. Acta Psychiatr
Scand 2022:146(1):51-63.
|
|
182 |
Lähteenvuo M, Luykx JJ, Taipale H, Mittendorfer-Rutz E, Tanskanen A, Batalla A, Tiihonen J. Associations between antipsychotic use, substance use and relapse risk in patients with schizophrenia: real-world evidence from two national cohorts. Br J
Psychiatry 2022:221(6):758-765.
|
|
183 |
Lähteenvuo M, Taipale H, Tanskanen A, Rannanpää S, Tiihonen J. Courses of treatment and risk factors for treatment-resistant depression in Finnish primary and special healthcare: A nationwide cohort study. J Affect Disord
2022:308:236-242.
|
|
184 |
Noppari T, Sun L, Lukkarinen L, Putkinen V, Tani P, Lindberg N, Saure E, Lauerma H, Tiihonen J, Venetjoki N, Salomaa M, Rautio P, Hirvonen J, Salmi J, Nummenmaa L. Brain structural alterations in autism and criminal psychopathy. Neuroimage
Clin 2022:35:103116.
|
|
185 |
Ojansuu I, Lähteenvuo M, Tiihonen J, Lehti M, Putkonen H. Psychosis and the risk of stranger homicides. Schizophr Bull 2022:3(1):sgac021.
|
|
186 |
Okhuijsen-Pfeifer C, van der Horst MZ, Bousman CA, Lin B, van Eijk KR, Ripke S, Ayhan Y, Babaoglu MO, Bak M, Alink W, van Beek H, Beld E, Bouhuis A, ..., Hallikainen T, Lähteenvuo M, Repo-Tiihonen E, Tuppurainen H, Tiihonen J, et al. Genome-wide
association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders. Transl Psychiatry 2022:12(1):145.
|
|
187 |
Paljarvi T, Forton J, Luciano S, Herttua K, Fazel S. Analysis of Neuropsychiatric Diagnoses After Montelukast Initiation. JAMA Netw Open 2022:5(5):e2213643.
|
|
188 |
Paljarvi T, McPherson T, Luciano S, Herttua K, Fazel S. Isotretinoin and adverse neuropsychiatric outcomes: retrospective cohort study using routine data. Br J Dermatol 2022:187(1):64-72.
|
|
189 |
Pauli M, Ölund Alonso H, Liljeberg J, Gustavsson P, Tiihonen J, Howner K. Exploring the relation between high-activity COMT Val158Met genotype and psychopathy in male offenders. J Forensic Psychiatry Psychol 2022:33(1):172-177.
|
|
190 |
Poranen J, Koistinaho A, Tanskanen A, Tiihonen J, Taipale H, Lähteenvuo M. Twenty-year medication use trends in first-episode bipolar disorder. Acta Psychiatr Scand 2022:146(6):583-593.
|
|
191 |
Rahman S, Filatova S, Chen L, Bjökenstam E, Taipale H, Mittendorfner-Rutz E. Trajectories of antidepressant use and characteristics associated with trajectory groups among young refugees and their Swedish-born peers with diagnosed common mental
disordersfindings from the REMAIN study. Soc Psychiatry Psychiatr Epidemiol 2022:57(2):305-317.
|
|
192 |
Rantanen N, Lieslehto J, Oksanen L-M, Oksanen SA, Anttila V-J, Lehtonen L, Geneid A, Sanmark E. Mental well-being of healthcare workers in 2 hospital districts during the first wave of the COVID-19 pandemic in Finland: a cross-sectional study. Int
J Occup Environ Health 2022:35(6):707-718.
|
|
193 |
Räsänen N, Tiihonen J, Koskuvi M, Lehtonen S, Koistinaho J. The iPSC perspective on schizophrenia. Trends Neurosci 2022:45(1):8-26.
|
|
194 |
Sabe M, Pillinger T, Kaiser S, Chen C, Taipale H, Tanskanen A, Tiihonen J, Leucht S, Correll CU, Solmi M. Half a century of research on antipsychotics and schizophrenia: A scientometric study of hotspots, nodes, bursts, and trends. Neurosci
Biobehav Rev 2022:136:104608.
|
|
195 |
Solmi M, Estradé A , Thompson T, Agorastos A, Radua J, ..., Tiihonen J, et al. Physical and mental health impact of COVID-19 on children, adolescents, and their families: The Collaborative Outcomes study on Health and Functioning during Infection
Times - Children and Adolescents (COH-FIT-C&A). . J Affect Disord 2022:299:367-376.
|
|
196 |
Solmi M, Estradé A, Thompson T, Agorastos A, Radua J, ..., Tiihonen J, et al. The collaborative outcomes study on health and functioning during infection times in adults (COH-FIT-Adults): Design and methods of an international online survey targeting
physical and mental health effects of the COVID-19 pandemic. J Affect Disord 2022:299:393-407.
|
|
197 |
Solmi M, Taipale H, Holm M, Tanskanen A, Mittendorfer-Rutz E, Correll CU, Tiihonen J. Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With
First-Episode Nonaffective Psychosis. Am J Psychiatry 2022:179(12):938-946.
|
|
198 |
Solmi M, Tiihonen J, Lähteenvuo M, Tanskanen A, Correll CU, Taipale H. Antipsychotics Use Is Associated With Greater Adherence to Cardiometabolic Medications in Patients With Schizophrenia: Results From a Nationwide, Within-subject Design Study.
Schizophr Bull 2022:48(1):166-175.
|
|
199 |
Stenius J, Heinonen E, Lindfors J, Holma J, Knekt P. Ego Impairment Index (EII-2) as a predictor of outcome in short- and long-term psychotherapy during a 5-year follow-up. J Clin Psychol 2022:78(9):1739-1751.
|
|
200 |
Sun L, Lukkarinen L, Noppari T, Nazari-Farsani S, Putkinen V, Seppälä K, Hudson M, Tani P, Lindberg N, Karlsson HK, Hirvonen J, Salomaa M, Venetjoki N, Lauerma H, Tiihonen J, Nummenmaa L. Aberrant motor contagion of emotions in psychopathy and
high-functioning autism. Cereb Cortex 2022:33(2):374-384.
|
|
201 |
Sun L, Lukkarinen L, Putkinen V, Karlsson HK, Hirvonen J, Tiihonen J, Lauerma H, Scott S, Nummenmaa L. Mu-opioid receptor system modulates responses to vocal bonding and distress signals in humans. Philos Trans R Soc Lond B Biol Sci
2022:377(1863):20210181.
|
|
202 |
Taipale H, Lähteenvuo M, Tanskanen A, Huoponen S, Rannanpää S, Tiihonen J. Healthcare utilization, costs, and productivity losses in treatment-resistant depression in Finland - a matched cohort study. BMC Psychiatry 2022:22(1):484.
|
|
203 |
Taipale H, Schneider-Thoma J, Pinzón-Espinosa J, Radua J, Efthimiou O, Vinkers CH, Mittendorfer-Rutz E, Cardoner N, Pintor L, Tanskanen A, Tomlinson A, Fusar-Poli P, Cipriani A, Vieta E, Leucht S, Tiihonen J, Luykx JJ. Representation and Outcomes of
Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials. JAMA Psychiatry 2022:79(3):210-218.
|
|
204 |
Taipale H, Tanskanen A, Correll CU, Tiihonen J. Real-world effectiveness of antipsychotic doses for relapse prevention in patients with first-episode schizophrenia in Finland: a nationwide, register-based cohort study. Lancet Psychiatry
2022:9(4):271-279.
|
|
205 |
Taipale H, Tanskanen A, Correll CU, Tiihonen J. Real-world effectiveness studies of low doses of antipsychotics - Authors' reply. Lancet Psychiatry 2022:9(7):536-537.
|
|
206 |
Taipale H, Tanskanen A, Luykx JJ, Solmi M, Leucht S, Correll CU, Tiihonen J. Optimal Doses of Specific Antipsychotics for Relapse Prevention in a Nationwide Cohort of Patients with Schizophrenia. Schizophr Bull 2022:48(4):774-784.
|
|
207 |
Tiihonen J, Tanskanen A, Bell JS, Dawson JL, Kataja V, Taipale H. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in
Finland. Lancet Psychiatry 2022:9(5):353-362.
|
|
208 |
Tiihonen J, Tanskanen A, Bell JS, Dawson JL, Kataja V, Taipale H. Clozapine and the risk of haematological malignancies - Authors' reply. Lancet Psychiatry 2022:9(7):539-540.
|
|
209 |
Vallius S, Taipale H, Koponen M, Tolppanen A, Tanskanen A, Hartikainen S, Tiihonen M. Automated multi-dose dispensing in persons with and without Alzheimer's disease-impacts on pharmacotherapy. Eur J Clin Pharmacol 2022:78(3):513-521.
|
|
210 |
Vaurio O, Lähteenvuo M, Kautiainen H, Repo-Tiihonen E, Tiihonen J. Female Psychopathy and Mortality. Front Psychiatry 2022:13:831410.
|
|
211 |
Vu M, Kettunen R, Tolppanen A, Hartikainen S, Taipale H. Statin discontinuation in persons with and without Alzheimer's disease. Eur J Clin Pharmacol 2022:78(7):1145-1153.
|
|
212 |
Checknita D, Tiihonen J, Hodgins S, Nilsson KW. Associations of age, sex, sexual abuse, and genotype with monoamine oxidase a gene methylation. J Neural Transm 2021:128(11):1721-1739.
|
|
213 |
Di Thiene D, Helgesson M, Rahman S, Alexanderson K, Tiihonen J, La Torre G, Mittendorfer-Rutz E. Risk of labour market marginalisation among young refugees and non-refugee migrants with common mental disorders. Soc Psychiatry Psychiatr
Epidemiol 2021:56(6):1025-1034.
|
|
214 |
Guinart D, Taipale H, Rubio JM, Tanskanen A, Correll CU, Tiihonen J, Kane JM. Risk Factors, Incidence, and Outcomes of Neuroleptic Malignant Syndrome on Long-Acting Injectable vs Oral Antipsychotics in a Nationwide Schizophrenia Cohort. Schizophr
Bull 2021:47(6):1621-1630.
|
|
215 |
Hakala A, Tolppanen A, Koponen M, Taipale H, Tanskanen A, Hartikainen S, Tiihonen M. Does Recent Hospitalization Increase Antipsychotic Initiation Among Community Dwellers With Alzheimer's Disease? J Am Med Dir Assoc
2021:22(7):1543-1547.e3.
|
|
216 |
Heikkinen M, Taipale H, Tanskanen A, Mittendorfer-Rutz E, Lähteenvuo M, Tiihonen J. Real-world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation-wide cohort of 125 556 patients. Addiction
2021:116(8):1990-1998.
|
|
217 |
Helgesson M, Rahman S, Björkenstam E, Gustafsson K, Amin R, Taipale H, Tanskanen A, Ekselius L, Mittendorfer-Rutz E. Trajectories of labour market marginalisation among young adults with newly diagnosed attention-deficit/hyperactivity disorder
(ADHD). Epidemiol Psychiatr Sci 2021:30:e67.
|
|
218 |
Hentilä E, Tiihonen M, Taipale H, Hartikainen S, Tolppanen A. Incidence of antidepressant use among community dwellers with and without Parkinson's disease - a nationwide cohort study. BMC Geriatr 2021:21(1):202.
|
|
219 |
Hipp K, Repo-Tiihonen E, Kuosmanen L, Katajisto J, Kangasniemi M. Patient participation in pro re nata medication in forensic psychiatric care: A nursing document analysis. J Psychiatr Mental Health Nurs 2021:28(4):611-621.
|
|
220 |
Holm M, Taipale H, Tanskanen A, Tiihonen J, Mitterdorfer-Rutz E. Employment among people with schizophrenia or bipolar disorder: A population-based study using nationwide registers. Acta Physiol Scand 2021:143(1):61-71.
|
|
221 |
Isohanni M, Jääskeläinen E, Miller BJ, Hulkko A, Tiihonen J, Möller H-J, Hartikainen S, Huhtaniska S, Lieslehto J. Medication management of antipsychotic treatment in schizophrenia - a narrative review. Hum Psychopharmacol Clin Exp
2021:36:e2765.
|
|
222 |
Kekkonen V, Kallioniemi E, Kaarre O, Könönen M, Kivimäki P, Gröhn H, Tolmunen T, Vanninen R. Heavy drinking from adolescence to young adulthood is associated with an altered cerebellum. Alcohol 2021:92:35-40.
|
|
223 |
Konte B, Walters JT, Rujescu D, Legge SE, Pardińas AF, Cohen D, Pirmohamed M, Tiihonen J, Hartmann AM, Bogers JP, van der Weide J, van der Weide K, Putkonen A, Repo-Tiihonen E, Hallikainen T, Silva E, Ingimarsson O, Sigurdsson E, et al. HLA-DQB1
6672G>C (rs113332494) is associated with clozapine-induced neutropenia and agranulocytosis in individuals of European ancestry. Transl Psychiatry 2021:11(1):214.
|
|
224 |
Kuosmanen A, Tiihonen J, Repo-Tiihonen E, Eronen M, Turunen H. Nurses' views highlight a need for the systematic development of patient safety culture in forensic psychiatry nursing. J Patient Saf 2021:17(3):e228-e233.
|
|
225 |
Kärkkäinen O, Kokla M, Lehtonen M, Auriola S, Martiskainen M, Tiihonen J, Karhunen PJ, Hanhineva K, Kok E. Changes in the metabolic profile of human male postmortem frontal cortex and cerebrospinal fluid samples associated with heavy alcohol use.
Addict Biol 2021:26(6):e13035.
|
|
226 |
Lampela P, Tanskanen A, Lähteenvuo M, Tiihonen J, Taipale H. Switches and early discontinuations of antidepressant medication in young adults with depression. J Affect Disord 2021:295:1474-1481.
|
|
227 |
Laukkanen E, Kuosmanen L, Louheranta O, Ryynänen O, Vehviläinen-Julkunen K. A Bayesian network model to identify the associations between the use of seclusion in psychiatric care and nursing managers' attitudes towards containment methods. J
Psychiatr Mental Health Nurs 2021:28(5):815-828.
|
|
228 |
Leucht S, Tiihonen J. Clozapine, long-acting injectables (and polypharmacy?) superior in U.S. and international registries. Editorial. Am J Psychiatry 2021:178(10):888-889.
|
|
229 |
Lieslehto J, Jääskeläinen E, Kiviniemi V, Haapea M, Jones PB, Murray GK, Veijola J, Dannlowski U, Grotegerd D, Meinert S, Hahn T, Ruef A, Isohanni M, Falkai P, Miettunen J, Dwyer DB, Koutsouleris N. The progression of disorder-specific brain pattern
expression in schizophrenia over 9 years. NPJ Schizophr 2021:7(1):32.
|
|
230 |
Lintunen J, Lähteenvuo M, Tiihonen J, Tanskanen A, Taipale H. Adenosine modulators and calcium channel blockers as add-on treatment for schizophrenia. NPJ Schizophr 2021:7(1):1.
|
|
231 |
Lintunen J, Taipale H, Tanskanen A, Mittendorfer-Rutz E, Tiihonen J, Lähteenvuo M. Long-Term Real-World Effectiveness of Pharmacotherapies for Schizoaffective Disorder. Schizophr Bull 2021:47(4):1099-1107.
|
|
232 |
Luykx JJ, Tiihonen J. Antipsychotic discontinuation: mind the patient and the real-world evidence. Lancet Psychiatry 2021:8(7):555-557.
|
|
233 |
Lähteenvuo M, Batalla A, Luykx JJ, Mittendorfer-Rutz E, Tanskanen A, Tiihonen J, Taipale H. Morbidity and mortality in schizophrenia with comorbid substance use disorders. Acta Psychiatr Scand 2021:144(1):42-49.
|
|
234 |
Lähteenvuo M, Taipale H, Tanskanen A, Mittendorfer-Rutz E, Tiihonen J. Effectiveness of pharmacotherapies for delusional disorder in a Swedish national cohort of 9076 patients. Schizophr Res 2021:228:367-372.
|
|
235 |
Lähteenvuo M, Tiihonen J. Antipsychotic Polypharmacy for the Management of Schizophrenia: Evidence and Recommendations. Drugs 2021:81(11):1273-1284.
|
|
236 |
López-Rubio C, Koponen M, Lampela P, Taipale H, Tanskanen A, Bell JS, Tolppanen A, Hartikainen S. Changes in the use of diabetes drugs among community-dwelling people with Alzheimer's disease. BMC Geriatr 2021:21(1):701.
|
|
237 |
Mazumder AH, Barnett J, Isometsä ET, Lindberg N, Torniainen-Holm M, Lähteenvuo M, Lahdensuo K, Kerkelä M, Ahola-Olli A, Hietala J, Kampman O, Kieseppä T, Jukuri T, Häkkinen K, Cederlöf E, Haaki W, Kajanne R, ..., Tiihonen J, et al. Reaction time and
visual memory in connection to alcohol use in persons with bipolar disorder. Brain Sci 2021:11(9):1154.
|
|
238 |
Mazumder AH, Barnett J, Isometsä ET, Lindberg N, Torniainen-Holm M, Lähteenvuo M, Lahdensuo K, Kerkelä M, Ahola-Olli A, Hietala J, Kampman O, Kieseppä T, Jukuri T, Häkkinen K, Cederlöf E, Haaki W, Kajanne R, ..., Tiihonen J, et al. Reaction time and
visual memory in connection to hazardous drinking polygenic scores in schizophrenia, schizoaffective disorder and bipolar disorder. Brain Sci 2021:11(11):1422.
|
|
239 |
Mazumder AH, Barnett J, Lindberg N, Torniainen-Holm M, Lähteenvuo M, Lahdensuo K, Kerkelä M, Hietala J, Isometsä ET, Kampman O, Kieseppä T, Jukuri T, Häkkinen K, Cederlöf E, Haaki W, Kajanne R, ..., Tiihonen J, et al. Reaction Time and Visual Memory
in Connection with Alcohol Use in Schizophrenia and Schizoaffective Disorder. Brain Sci 2021:11(6):688.
|
|
240 |
Nummenmaa L, Lukkarinen L, Sun L, Putkinen V, Seppälä K, Karjalainen T, Karlsson HK, Hudson M, Venetjoki N, Salomaa M, Rautio P, Hirvonen J, Lauerma H, Tiihonen J. Brain basis of psychopathy in criminal offenders and general population. Cereb
Cortex 2021:31(9):4104-4114.
|
|
241 |
Pisa F, Reinold J, Lavikainen P, Koponen M, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A. Hip Fracture Risk in Antiepileptic Drug Initiators and Non-Initiators with Alzheimer's Disease. Clin Epidemiol 2021:13:295-307.
|
|
242 |
Reutfors J, Andersson TM, Tanskanen A, DiBernardo A, Li G, Brandt L, Brenner P. Risk factors for suicide and suicide attempts among patients with treatment-resistant depression: nested case-control study. Arch Suicide Res
2021:25(3):424-438.
|
|
243 |
Rubio JM, Taipale H, Tanskanen A, Correll CU, Kane JM, Tiihonen J. Long-term Continuity of Antipsychotic Treatment for Schizophrenia: A Nationwide Study. Schizophr Bull 2021:47(6):1611-1620.
|
|
244 |
Saarinen A, Keltikangas-Järvinen L, Jääskeläinen E, Huhtaniska S, Pudas J, Tovar-Perdomo S, Penttilä M, Miettunen J, Lieslehto J. Early Adversity and Emotion Processing From Faces: A Meta-analysis on Behavioral and Neurophysiological Responses.
Biol Psychiatry Cogn Neurosci Neuroimaging 2021:6(7):692-705.
|
|
245 |
Stenius J, Knekt P, Heinonen E, Holma J, Antikainen R, Lindfors O. Predicting the working alliance over the course of long-term psychodynamic psychotherapy with the Rorschach Ego Impairment Index, self-reported defense style, and performance-based
intelligence: An evaluation of three methodological approaches. Psychoanal Psychol 2021:38(1):58-67.
|
|
246 |
Taipale H, Lähteenvuo M, Tanskanen A, Mittendorfer-Rutz E, Tiihonen J. Comparative Effectiveness of Antipsychotics for Risk of Attempted or Completed Suicide Among Persons With Schizophrenia. Schizophr Bull 2021:47(1):23-30.
|
|
247 |
Taipale H, Niederkrotenthaler T, Helgesson M, Sijbrandij M, Berg L, Tanskanen A, Mittendorfer-Rutz E. Initiation of antidepressant use among refugee and Swedish-born youth after diagnosis of a common mental disorder: findings from the REMAIN study .
Soc Psychiatry Psychiatr Epidemiol 2021:56(3):463-474.
|
|
248 |
Taipale H, Niederkrotenthaler T, Tanskanen A, Cullen AE, Helgesson M, Berg L, Sijbrandij M, Klimek P, Mittendorfer-Rutz E. Persistence of antidepressant use among refugee youth with common mental disorder. J Affect Disord
2021:294:831-837.
|
|
249 |
Taipale H, Puranen A, Mittendorfer-Rutz E, Tiihonen J, Tanskanen A, Cervenka S, Lähteenvuo M. Antipsychotic use among persons with schizophrenia in Sweden and Finland, trends and differences. Nord J Psychiatry 2021:75(5):315-322.
|
|
250 |
Taipale H, Solmi M, Lähteenvuo M, Tanskanen A, Correll CU, Tiihonen J. Antipsychotic use and risk of breast cancer in women with schizophrenia: a nationwide nested case-control study in Finland. Lancet Psychiatry 2021:8(10):883-891.
|
|
251 |
Taipale H, Tiihonen J. Registry-based studies: What they can tell us, and what they cannot. Eur Neuropsychopharmacology 2021:45:35-37.
|
|
252 |
Tanskanen A, Taipale H, Cannon M, Cotter D, Tiihonen J. Incidence of schizophrenia and influence of prenatal and infant exposure to viral infectious diseases. Acta Psychiatr Scand 2021:143(6):487-494.
|
|
253 |
Tarvainen A, Hartikainen S, Taipale H, Tanskanen A, Koponen M, Tolppanen AM. Association of recent hospitalisation with antidepressant initiation among community dwellers with Alzheimer's disease. Int J Geriatr Psychiatry
2021:36(7):1075-1084.
|
|
254 |
Tiihonen J, Koskuvi M, Lähteenvuo M, Trontti K, Ojansuu I, Vaurio O, Cannon TD, Lönnqvist J, Therman S, Suvisaari J, Cheng L, Tanskanen A, Taipale H, Lehtonen S, Koistinaho J. Molecular signaling pathways underlying schizophrenia. Schizophr
Res 2021:232:33-41.
|
|
255 |
Antolķn-Concha D, Lähteenvuo M, Vattulainen P, Tanskanen A, Taipale H, Vieta E, Tiihonen J. Suicide mortality and use of psychotropic drugs in patients hospitalized due to bipolar disorder: A Finnish nationwide cohort study. J Affect Disord
2020:277:885-892.
|
|
256 |
Asikainen J, Louheranta O, Vehviläinen-Julkunen K, Repo-Tiihonen E. Use of coercion prevention tools in Finnish psychiatric wards. Arch Psychiatr Nurs 2020:34(5):412-420.
|
|
257 |
Asikainen J, Vehviläinen-Julkunen K, Repo-Tiihonen E, Louheranta O. Violence factors and debriefing in psychiatric inpatient care: A Review . J Psychosoc Nurs Ment Health Serv 2020:58(5):39-49.
|
|
258 |
Braithwaite B, Paananen J, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A. Detection of medications associated with Alzheimer's disease using ensemble methods and cooperative game theory. Int J Med Inf 2020:141:104142.
|
|
259 |
Checknita D, Bendre M, Ekström TJ, Comasco E, Tiihonen J, Hodgins S, Nilsson KW. Monoamine oxidase A genotype and methylation moderate the association of maltreatment and aggressive behaviour. Behav Brain Res 2020:382:112476.
|
|
260 |
Hamina A, Tanskanen A, Tiihonen J, Taipale H. Medication Use and Health Care Utilization After a Cost-sharing Increase in Schizophrenia: A Nationwide Analysis. Med Care 2020:58(9):763-769.
|
|
261 |
Hipp K, Repo-Tiihonen E, Kuosmanen L, Katajisto J, Kangasniemi M. PRN medication events in a forensic psychiatric hospital: a document analysis of the prevalence and reasons. Int J Forensic Ment Health 2020:19(4):329-340.
|
|
262 |
Johanson M, Vaurio O, Tiihonen J, Lähteenvuo M. A Systematic Literature Review of Neuroimaging of Psychopathic Traits. Front Psychiatry 2020:10:1027.
|
|
263 |
Lampela P, Tolppanen A, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Taipale H. Asthma and Chronic Obstructive Pulmonary Disease as a Comorbidity and Association with the Choice of Antidementia Medication Among Persons with Alzheimer's Disease.
J Alzheimers Dis 2020:73(3):1243-1251.
|
|
264 |
Laukkanen E, Kuosmanen L, Louheranta O, Vehviläinen-Julkunen K. Psychiatric nursing managers' attitudes towards containment methods in psychiatric inpatient care. J Nurs Manag 2020:28(3):699-709.
|
|
265 |
Laukkanen E, Kuosmanen L, Selander T, Vehviläinen-Julkunen K. Seclusion, restraint, and involuntary medication in Finnish psychiatric care: a register study with root-level data. Nord J Psychiatry 2020:74(6):439-443.
|
|
266 |
Lavikainen P, Koponen M, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A. Length of Hospital Stay for Hip Fracture and 30-Day Mortality in People With Alzheimer's Disease: A Cohort Study in Finland. J Gerontol A Biol Sci Med Sci
2020:75(11):2184-2192.
|
|
267 |
Lindeman S, Kolari T, Tiihonen J. Valproate and Neuroleptic Malignant Syndrome in an Elderly Patient With Schizoaffective Disorder. Prim Care Companion CNS Disord 2020:22(3):19/02542.
|
|
268 |
Lintula E, Tiihonen M, Taipale H, Tolppanen A, Tanskanen A, Tiihonen J, Hartikainen S, Hamina A. Opioid Use After Hospital Care due to Hip Fracture Among Community-Dwelling Persons With and Without Alzheimer's Disease. Drugs Aging
2020:37(3):193-203.
|
|
269 |
Luykx JJ, Stam N, Tanskanen A, Tiihonen J, Taipale H. In the aftermath of clozapine discontinuation: comparative effectiveness and safety of antipsychotics in patients with schizophrenia who discontinue clozapine. Br J Psychiatry
2020:217(3):498-505.
|
|
270 |
Puranen A, Koponen M, Tanskanen A, Tiihonen J, Taipale H. Use of antidepressants and mood stabilizers in persons with first-episode schizophrenia. Eur J Clin Pharmacol 2020:76(5):711-718.
|
|
271 |
Rubio JM, Schoretsanitis G, John M, Tiihonen J, Taipale H, Guinart D, Malhotra AK, Correll CU, Kane JM. Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual
participant data meta-analysis. Lancet Psychiatry 2020:7(9):749-761.
|
|
272 |
Rubio JM, Taipale H, Correll CU, Tanskanen A, Kane JM, Tiihonen J. Psychosis breakthrough on antipsychotic maintenance: results from a nationwide study. Psychol Med 2020:50(8):1356-1367.
|
|
273 |
Sarycheva T, Lavikainen P, Taipale H, Tiihonen J, Tanskanen A, Hartikainen S, Tolppanen A. Antiepileptic drug use and mortality among community-dwelling persons with Alzheimer disease. Neurology 2020:94(20):e2099-e2108.
|
|
274 |
Seppänen A, Joelsson P, Ahlgren-Rimpiläinen A, Repo-Tiihonen E. Forensic psychiatry in Finland: an overview of past, present and future. Int J Ment Health Syst 2020:14:29.
|
|
275 |
Sluggett JK, Koponen M, Bell JS, Taipale H, Tanskanen A, Tiihonen J, Uusitupa M, Tolppanen A, Hartikainen S. Metformin and Risk of Alzheimer's Disease Among Community-Dwelling People With Diabetes: A National Case-Control Study. J Clin Endocrinol
Metab 2020:105(4):dgz234.
|
|
276 |
Sommer IE, Tiihonen J, van Mourik A, Tanskanen A, Taipale H. The clinical course of schizophrenia in women and men-a nation-wide cohort study. NPJ Schizophr 2020:6(1):12.
|
|
277 |
Stam N, Taipale H, Tanskanen A, Isphording L, Okhuijsen-Pfeifer C, Schuiling-Veninga CC, Bos JH, Bijker BJ, Tiihonen J, Luykx JJ. Persistence of Antipsychotic Use After Clozapine Discontinuation: A Real-World Study Across Antipsychotics. Clin
Transl Sci 2020:13(6):1170-1177.
|
|
278 |
Taipale H, Rahman S, Tanskanen A, Mehtälä J, Hoti F, Jedenius E, Enkusson D, Leval A, Sermon J, Tiihonen J, Mittendorfer-Rutz E. Health and work disability outcomes in parents of patients with schizophrenia associated with antipsychotic exposure by
the offspring. Sci Rep 2020:10(1):1219.
|
|
279 |
Taipale H, Reutfors J, Tanskanen A, Brandt L, Tiihonen J, DiBernardo A, Mittendorfer-Rutz E, Brenner P. Risk and risk factors for disability pension among patients with treatment resistant depression- a matched cohort study. BMC Psychiatry
2020:20(1):232.
|
|
280 |
Taipale H, Särkilä H, Tanskanen A, Kurko T, Taiminen T, Tiihonen J, Sund R, Tuulio-Henriksson A, Saastamoinen L, Hietala J. Incidence of and Characteristics Associated With Long-term Benzodiazepine Use in Finland. JAMA Netw Open
2020:3(10):e2019029.
|
|
281 |
Taipale H, Tanskanen A, Mehtälä J, Vattulainen P, Correll CU, Tiihonen J. 20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20).
World Psychiatry 2020:19(1):61-68.
|
|
282 |
Tapiainen V, Lavikainen P, Koponen M, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A. The Risk of Head Injuries Associated With Antipsychotic Use Among Persons With Alzheimer's disease. J Am Geriatr Soc
2020:68(3):595-602.
|
|
283 |
Tiihonen J, Koskuvi M, Lähteenvuo M, Virtanen PL, Ojansuu I, Vaurio O, Gao Y, Hyötyläinen I, Puttonen KA, Repo-Tiihonen E, Paunio T, Rautiainen M, Tyni S, Koistinaho J, Lehtonen S. Neurobiological roots of psychopathy. Mol Psychiatry
2020:25(12):3432-3441.
|
|
284 |
Tiihonen J, Taipale H, Correll CU. Commentary on Robert Whitaker's viewpoint. Psychol Med 2020:50(16):2653-2654.
|
|
285 |
Tiihonen J, Taipale H, Correll CU. Rejoinder to rejoinder to commentary. Psychol Med 2020:50(16):2812-2813.
|
|
286 |
Tolppanen A, Taipale H, Koponen M, Tiihonen J, Hartikainen S. Causes of death in a nationwide cohort of community-dwellers with Alzheimer's disease. BMC Geriatr 2020:20(1):441.
|
|
287 |
Vu M, Koponen M, Taipale H, Tanskanen A, Tiihonen J, Kettunen R, Hartikainen S, Tolppanen A. Prevalence of cardiovascular drug use before and after diagnosis of Alzheimer's disease. Int J Cardiol 2020:300:221-225.
|
|
288 |
Budhiraja M, Pereira JB, Lindner P, Westman E, Jokinen J, Savic I, Tiihonen J, Hodgins S. Cortical structure abnormalities in females with conduct disorder prior to age 15. Psychiatry Res Neuroimaging 2019:289:37-44.
|
|
289 |
Di Thiene D, Mittendorfer-Rutz E, Rahman S, Wang M, Alexanderson K, Tiihonen J, La Torre G, Helgesson M. Trajectories of sickness absence, disability pension and unemployment in young immigrants with common mental disorders. Eur J Public
Health 2019:29(6):1055-1062.
|
|
290 |
Forsman J, Taipale H, Masterman T, Tiihonen J, Tanskanen A. Adherence to psychotropic medication in completed suicide in Sweden 2006-2013: a forensic-toxicological matched case-control study. Eur J Clin Pharmacol 2019:75(10):1421-1430.
|
|
291 |
Hamina A, Taipale H, Karttunen N, Tanskanen A, Tiihonen J, Tolppanen A, Hartikainen S. Hospital-Treated Pneumonia Associated with Opioid Use Among Community Dwellers with Alzheimer's Disease. J Alzheimers Dis 2019:69(3):807-816.
|
|
292 |
Heikkinen N, Kärkkäinen O, Laukkanen E, Kekkonen V, Kaarre O, Kivimäki P, Könönen M, Velagapudi V, Nandania J, Lehto SM, Niskanen E, Vanninen R, Tolmunen T. Changes in the serum metabolite profile correlate with decreased brain gray matter volume in
moderate-to-heavy drinking young adults. Alcohol 2019:75:89-97.
|
|
293 |
Ilmaniemi S, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen AM. Incidence of head injury and traumatic brain injury among people with Alzheimer's disease. J Epidemiol Community Health 2019:73(5):451-454.
|
|
294 |
Kalamägi J, Lavikainen P, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A. Predictors of high hospital care and medication costs and cost trajectories in community-dwellers with Alzheimer's disease. Ann Med
2019:51(5):294-305.
|
|
295 |
Kallioniemi E, Kärkkäinen O, Määttä S, Könönen M, Kivimäki P, Kaarre O, Velagapudi V, Kekkonen V, Lehto SM, Laukkanen E, Tolmunen T. Repeated Transcranial Magnetic Stimulation-Induced Motor Evoked Potentials Correlate With the Subject-Specific Serum
Metabolic Profile of Creatine. J Clin Neurophysiol 2019:36(3):229-235.
|
|
296 |
Karttunen N, Taipale H, Hamina A, Tanskanen A, Tiihonen J, Tolppanen A, Hartikainen S. Concomitant use of benzodiazepines and opioids in community-dwelling older people with or without Alzheimer's disease-A nationwide register-based study in Finland.
Int J Geriatr Psychiatry 2019:34(2):280-288.
|
|
297 |
Kettunen R, Taipale H, Tolppanen A, Tanskanen A, Tiihonen J, Hartikainen S, Koponen M. Duration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer's disease. Eur J Clin
Pharmacol 2019:75(3):417-425.
|
|
298 |
Koponen M, Lavikainen P, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A. Accumulation of Hospital Days Among Antipsychotic Initiators With Alzheimer's Disease. J Am Med Dir Assoc 2019:20(12):1488-1494.e3.
|
|
299 |
Kuosmanen A, Tiihonen J, Repo-Tiihonen E, Eronen M, Turunen H. Changes in patient safety culture: A patient safety intervention for Finnish forensic psychiatric hospital staff. J Nurs Manag 2019:27(4):848-857.
|
|
300 |
Laukkanen E, Vehviläinen-Julkunen K, Louheranta O, Kuosmanen L. Psychiatric nursing staffs' attitudes towards the use of containment methods in psychiatric inpatient care: An integrative review. Int J Ment Health Nurs
2019:28(2):390-406.
|
|
301 |
Laukkanen V, Kärkkäinen O, Kautiainen H, Tiihonen J, Storvik M. Increased [³H]quisqualic acid binding density in the dorsal striatum and anterior insula of alcoholics: A post-mortem whole-hemisphere autoradiography study. Psychiatry Res
Neuroimaging 2019:287:63-69.
|
|
302 |
Lavikainen P, Taipale H, Tanskanen A, Koponen M, Tiihonen J, Hartikainen S, Tolppanen A. Antiepileptic Drugs and Accumulation of Hospital Days Among Persons With Alzheimer's Disease. J Am Med Dir Assoc 2019:20(6):751-758.
|
|
303 |
Maron E, Baldwin DS, Balotsev R, ..., Lähteenvuo M, ..., Tiihonen J, et al. Manifesto for an international digital mental health network. Digital Psychiatry 2019:2(1):14-24.
|
|
304 |
Mittendorfer-Rutz E, Rahman S, Tanskanen A, Majak M, Mehtälä J, Hoti F, Jedenius E, Enkusson D, Leval A, Sermon J, Taipale H, Tiihonen J. Burden for Parents of Patients With Schizophrenia-A Nationwide Comparative Study of Parents of Offspring With
Rheumatoid Arthritis, Multiple Sclerosis, Epilepsy, and Healthy Controls. Schizophr Bull 2019:45(4):794-803.
|
|
305 |
Ojansuu I, Putkonen H, Lähteenvuo M, Tiihonen J. Substance Abuse and Excessive Mortality Among Forensic Psychiatric Patients: A Finnish Nationwide Cohort Study. Front Psychiatry 2019:10:678.
|
|
306 |
Pacchiarotti I, Tiihonen J, Kotzalidis GD, Verdolini N, Murru A, Goikolea JM, Valentķ M, Aedo A, Vieta E. Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: A systematic review. Eur
Neuropsychopharmacology 2019:29(4):457-470.
|
|
307 |
Shen Q, Heikkinen N, Kärkkäinen O, Gröhn H, Könönen M, Liu Y, Kaarre O, Zhang Z, Tan C, Tolmunen T, Vanninen R. Effects of long-term adolescent alcohol consumption on white matter integrity and their correlations with metabolic alterations.
Psychiatry Res Neuroimaging 2019:294:111003.
|
|
308 |
Taipale H, Hamina A, Karttunen N, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A. Incident opioid use and risk of hip fracture among persons with Alzheimer disease: a nationwide matched cohort study. Pain
2019:160(2):417-423.
|
|
309 |
Taipale H, Lampela P, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A. Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study. J
Alzheimers Dis 2019:68(1):127-136.
|
|
310 |
Taipale H, Rysä J, Hukkanen J, Koponen M, Tanskanen A, Tiihonen J, Kröger H, Hartikainen S, Tolppanen A. Long-term thiazide use and risk of low-energy fractures among persons with Alzheimer's disease-nested case-control study. Osteoporos Int
2019:30(7):1481-1489.
|
|
311 |
Tiihonen J, Koskuvi M, Storvik M, Hyötyläinen I, Gao Y, Puttonen KA, Giniatullina R, Poguzhelskaya E, Ojansuu I, Vaurio O, Cannon TD, Lönnqvist J, Therman S, Suvisaari J, Kaprio J, Cheng L, Hill AF, Lähteenvuo M, et al. Sex-specific transcriptional
and proteomic signatures in schizophrenia. Nat Commun 2019:10(1):3933.
|
|
312 |
Tiihonen J, Taipale H, Mehtälä J, Vattulainen P, Correll CU, Tanskanen A. Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia. JAMA Psychiatry 2019:76(5):499-507.
|
|
313 |
Weizmann-Henelius G, Putkonen H, Rissanen T, Eronen M, Webster CD. Exploring a new structured professional judgment measure (impulsivity measure related to violence) after an average follow-up of 10 years: A study of Finnish offenders. Crim Behav
Ment Health 2019:29(1):57-68.
|
|
314 |
Aregbesola A, Onyeka IN, Olubamwo O, Ronkainen K, Tiihonen J, Föhr J, Kauhanen J. Diabetes hospitalizations and deaths in a cohort of treatment-seeking illicit drug users. SAGE Open Med 2018:6:2050312118768164.
|
|
315 |
Askola R, Nikkonen M, Paavilainen E, Soininen P, Putkonen H, Louheranta O. Forensic Psychiatric Patients' Perspectives on Their Care: A Narrative View. Perspect Psychiatr Care 2018:54(1):64-73.
|
|
316 |
Bendre M, Comasco E, Checknita D, Tiihonen J, Hodgins S, Nilsson KW. Associations between MAOA-uVNTR genotype, maltreatment, MAOA methylation, and alcohol consumption in young adult males. Alcohol Clin Exp Res 2018:42(3):508-519.
|
|
317 |
Checknita D, Ekström TJ, Comasco E, Nilsson KW, Tiihonen J, Hodgins S. Associations of monoamine oxidase A gene first exon methylation with sexual abuse and current depression in women. J Neural Transm 2018:125(7):1053-1064.
|
|
318 |
Di Thiene D, Rahman S, Helgesson M, Wang M, Alexanderson K, Tiihonen J, La Torre G, Mittendorfer-Rutz E. Healthcare use among immigrants and natives in Sweden on disability pension, before and after changes of regulations. Eur J Public Health
2018:28(3):445-451.
|
|
319 |
Forsman J, Taipale H, Masterman T, Tiihonen J, Tanskanen A. Comparison of dispensed medications and forensic-toxicological findings to assess pharmacotherapy in the Swedish population 2006 to 2013. Pharmacoepidemiol Drug Saf
2018:27(10):1112-1122.
|
|
320 |
Hamina A, Lavikainen P, Tanskanen A, Tolppanen A-M, Tiihonen J, Hartikainen S, Taipale H. Impact of opioid initiation on antipsychotic and benzodiazepine and related drug use among persons with Alzheimer's disease. Int Psychogeriatr
2018:30(7):947-956.
|
|
321 |
Hipp K, Kuosmanen L, Repo-Tiihonen E, Leinonen M, Louheranta O, Kangasniemi M. Patient participation in pro re nata medication in psychiatric inpatient settings: An integrative review. Int J Ment Health Nurs 2018:27(2):536-554.
|
|
322 |
Jokinen J, Königsson J, Moberg T, Jönsson EG, Tiihonen J, Nordström P, Oreland L, Åsberg M. Platelet monoamine oxidase activity and interpersonal violence in male suicide attempters. Psychiatry Res 2018:260:173-176.
|
|
323 |
Järvinen H, Taipale H, Koponen M, Tanskanen A, Tiihonen J, Tolppanen A-M, Hartikainen S. Hospitalization after oral antibiotic initiation in Finnish community dwellers with and without Alzheimer's disease: retrospective register-based cohort study.
J Alzheimers Dis 2018:64(2):437-445.
|
|
324 |
Järvinen H, Taipale H, Koponen M, Tanskanen A, Tiihonen J, Tolppanen A-M, Hartikainen S. Hospitalization after Oral Antibiotic Initiation in Finnish Community Dwellers with and without Alzheimer's Disease: Retrospective Register-Based Cohort Study.
J Alzheimers Dis 2018:64(2):437-445.
|
|
325 |
Kivimies K, Repo-Tiihonen E, Kautiainen H, Tiihonen J. Comorbid opioid use is undertreated among forensic patients with schizophrenia. Subst Abuse Treat Prev Policy 2018:13(1):39.
|
|
326 |
Kurko T, Saastamoinen LK, Tuulio-Henriksson A, Taiminen T, Tiihonen J, Airaksinen M, Hietala J. Trends in the long-term use of benzodiazepine anxiolytics and hypnotics: A national register study for 2006 to 2014. Pharmacoepidemiol Drug Saf
2018:27(6):674-682.
|
|
327 |
Lehikoinen AI, Kärkkäinen OK, Lehtonen MAS, Auriola SOK, Hanhineva KJ, Heinonen ST. Alcohol and substance use are associated with altered metabolome in the first trimester serum samples of pregnant mothers . Eur J Obstet Gynecol Reprod Biol
2018:223:79-84.
|
|
328 |
Lindner P, Flodin P, Budhiraja M, Savic I, Jokinen J, Tiihonen J, Hodgins S. Associations of Psychopathic Traits With Local and Global Brain Network Topology in Young Adult Women. Biol Psychiatry Cogn Neurosci Neuroimaging
2018:3(12):1003-1012.
|
|
329 |
Lindner P, Flodin P, Larm P, Budhiraja M, Savic-Berglund I, Jokinen J, Tiihonen J, Hodgins S. Amygdala-orbitofrontal structural and functional connectivity in females with anxiety disorders, with and without a history of conduct disorder. Sci
Rep 2018:8(1):1101.
|
|
330 |
Lähteenvuo M, Tanskanen A, Taipale H, Hoti F, Vattulainen P, Vieta E, Tiihonen J. Real-world effectiveness of pharmacologic treatments for the prevention of rehospitalization in a Finnish nationwide cohort of patients with bipolar disorder. JAMA
Psychiatry 2018:75(4):347-355.
|
|
331 |
Ojansuu I, Ojansuu I, Putkonen H, Tiihonen J. Cause-specific mortality in Finnish forensic psychiatric patients. Nord J Psychiatry 2018:72(5):374-379.
|
|
332 |
Olubamwo OO, Onyeka IN, Aregbesola A, Ronkainen K, Tiihonen J, Föhr J, Kauhanen J. Determinants of hospitalizations for pneumonia among Finnish drug users. SAGE Open Med 2018:6:2050312118784311.
|
|
333 |
Orsel K, Taipale H, Raatikainen S, Lampela P, Tolppanen A-M, Koponen M, Tanskanen A, Tiihonen J, Gardarsdottir H, Hartikainen S. Antipsychotic Use and the Risk of Initiating Medication for Benign Prostate Hyperplasia in Persons With Alzheimer
Disease: A Matched Cohort Study. J Clin Psychopharmacol 2018:38(5):494-497.
|
|
334 |
Orsel K, Taipale H, Tolppanen A-M, Koponen M, Tanskanen A, Tiihonen J, Gardarsdottir H, Hartikainen S. Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer's disease. Eur Neuropsychopharmacology
2018:28(11):1260-1269.
|
|
335 |
Saarelainen L, Tolppanen A-M, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Taipale H. Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: A matched cohort study. Int J Geriatr Psychiatry
2018:33(4):583-590.
|
|
336 |
Sarycheva T, Lavikainen P, Taipale H, Tiihonen J, Tanskanen A, Hartikainen S, Tolppanen A-M. Antiepileptic Drug Use and the Risk of Stroke Among Community-Dwelling People With Alzheimer Disease: A Matched Cohort Study. J Am Heart Assoc
2018:7(18):e009742.
|
|
337 |
Sarycheva T, Taipale H, Lavikainen P, Tiihonen J, Tanskanen A, Hartikainen S, Tolppanen A-M. Incidence and Prevalence of Antiepileptic Medication Use in Community-Dwelling Persons with and without Alzheimer's Disease. J Alzheimers Dis
2018:66(1):387-395.
|
|
338 |
Taipale H, Gomm W, Broich K, Maier W, Tolppanen A-M, Tanskanen A, Tiihonen J, Hartikainen S, Haenisch B. Use of Antiepileptic Drugs and Dementia Risk-an Analysis of Finnish Health Register and German Health Insurance Data. J Am Geriatr Soc
2018:66(6):1123-1129.
|
|
339 |
Taipale H, Hamina A, Lampela P, Tanskanen A, Tiihonen J, Karttunen N, Tolppanen A-M, Hartikainen S. Is Alzheimer's Disease Associated with Previous Opioid Use? Pain Med 2018:19(11):2115-2121.
|
|
340 |
Taipale H, Mehtälä J, Tanskanen A, Tiihonen J. Comparative Effectiveness of Antipsychotic Drugs for Rehospitalization in Schizophrenia-A Nationwide Study With 20-Year Follow-up. Schizophr Bull 2018:44(6):1381-1387.
|
|
341 |
Taipale H, Mittendorfer-Rutz E, Alexanderson K, Majak M, Mehtälä J, Hoti F, Jedenius E, Enkusson D, Leval A, Sermon J, Tanskanen A, Tiihonen J. Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia. Schizophr
Res 2018:197:274-280.
|
|
342 |
Tanskanen A, Tiihonen J, Taipale H. Mortality in schizophrenia: 30-year nationwide follow-up study. Acta Psychiatr Scand 2018:138(6):492-499.
|
|
343 |
Tapiainen V, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A-M. The risk of Alzheimer's disease associated with benzodiazepines and related drugs: a nested case-control study. Acta Psychiatr Scand 2018:138(2):91-100.
|
|
344 |
Thomson A, Tiihonen J, Miettunen J, Virkkunen M, Lindberg N. Firesetting and general criminal recidivism among a consecutive sample of Finnish pretrial male firesetters: A register-based follow-up study. Psychiatry Res 2018:259:377-384.
|
|
345 |
Tiihonen J. Response to the editorial on antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia. Schizophr Res 2018:202:397.
|
|
346 |
Tiihonen J, Tanskanen A, Taipale H. 20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia. Am J Psychiatry 2018:175(8):765-773.
|
|
347 |
Tiihonen J, Tanskanen A, Taipale H. Risk of Treatment Failure: Response to Czobor and Volavka. Am J Psychiatry 2018:175(9):909.
|
|
348 |
Tolppanen A-M, Tiihonen M, Taipale H, Koponen M, Tanskanen A, Lavikainen P, Tiihonen J, Hartikainen S. Systemic Estrogen Use and Discontinuation After Alzheimer's Disease Diagnosis in Finland 2005-2012: A Nationwide Exposure-Matched Cohort Study.
Drugs Aging 2018:35(11):985-992.
|
|
349 |
Torvinen-Kiiskinen S, Tolppanen A-M, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Taipale H. Proton pump inhibitor use and risk of hip fractures among community-dwelling persons with Alzheimer's disease-a nested case-control study. Aliment
Pharmacol Ther 2018:47(8):1135-1142.
|
|
350 |
Torvinen-Kiiskinen S, Tolppanen A-M, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Taipale H. Editorial: let's take a break from studying the PPI-fracture association-Authors' reply. Editorial. Aliment Pharmacol Ther
2018:47(11):1544-1545.
|
|
351 |
Vaurio O, Repo-Tiihonen E, Kautiainen H, Tiihonen J. Psychopathy and Mortality. J Forensic Sci 2018:63(2):474-477.
|
|
352 |
Wang M, Vaez M, Dorner TE, Tiihonen J, Voss M, Ivert T, Mittendorfer-Rutz E. Trajectories and characteristics of work disability before and after acute myocardial infarction. Heart 2018:104(4):340-348.
|
|
353 |
Wingård L, Taipale H, Reutfors J, Westerlund A, Bodén R, Tiihonen J, Tanskanen A, Andersen M. Initiation and long-term use of benzodiazepines and Z-drugs in bipolar disorder. Bipolar Disord 2018:20(7):634-646.
|
|
354 |
Ahola P, Joensuu M, Knekt P, Lindfors O, Saarinen P, Tolmunen T, Valkonen-Korhonen M, Jääskeläinen T, Virtala E, Tiihonen J, Lehtonen J. Effects of Scheduled Waiting for Psychotherapy in Patients With Major Depression. J Nerv Ment Dis
2017:205(8):611-617.
|
|
355 |
Askola R, Louheranta O, Soininen P, Putkonen H, Åstedt-Kurki P, Paavilainen E. The Offense as Perceived by the Parents of Forensic Psychiatric Patients. Issues Ment Health Nurs 2017:38(9):705-711.
|
|
356 |
Askola R, Nikkonen M, Putkonen H, Kylmä J, Louheranta O. The Therapeutic Approach to a Patient's Criminal Offense in a Forensic Mental Health Nurse-Patient Relationship-The Nurses' Perspectives. Perspect Psychiatr Care
2017:53(3):164-174.
|
|
357 |
Budhiraja M, Savic I, Lindner P, Jokinen J, Tiihonen J, Hodgins S. Brain structure abnormalities in young women who presented conduct disorder in childhood/adolescence. Cogn Affect Behav Neurosci 2017:17(4):869-885.
|
|
358 |
Di Thiene D, Helgesson M, Alexanderson K, La Torre G, Tiihonen J, Mittendorfer-Rutz E. Risk of disability pension in first and second generation immigrants: the role of age and region of birth in a prospective population-based study from Sweden.
BMC Public Health 2017:17(1):931.
|
|
359 |
Hamina A, Taipale H, Tanskanen A, Tolppanen A, Karttunen N, Pylkkänen L, Tiihonen J, Hartikainen S. Long-term use of opioids for nonmalignant pain among community-dwelling persons with and without Alzheimer disease in Finland: a nationwide
register-based study. Pain 2017:158(2):252-260.
|
|
360 |
Hamina A, Taipale H, Tanskanen A, Tolppanen A-M, Tiihonen J, Hartikainen S. Differences in analgesic use in community-dwelling persons with and without Alzheimer's disease. Eur J Pain 2017:21(4):658-667.
|
|
361 |
Hyttinen V, Taipale H, Tanskanen A, Tiihonen J, Tolppanen AM, Hartikainen S, Valtonen H. Risk Factors for Initiation of Potentially Inappropriate Medications in Community-Dwelling Older Adults with and without Alzheimer's Disease. Drugs Aging
2017:34(1):67-77.
|
|
362 |
Hyttinen V, Taipale H, Tolppanen A-M, Tanskanen A, Tiihonen J, Hartikainen S, Valtonen H. Incident Use of a Potentially Inappropriate Medication and Hip Fracture in Community-Dwelling Older Persons With Alzheimer's Disease. Ann Pharmacother
2017:51(9):725-734.
|
|
363 |
Imtiaz B, Taipale H, Tanskanen A, Tiihonen M, Kivipelto M, Heikkinen A, Tiihonen J, Soininen H, Hartikainen S, Tolppanen A. Risk of Alzheimer's disease among users of postmenopausal hormone therapy: A nationwide case-control study. Maturitas
2017:98:7-13.
|
|
364 |
Juntunen H, Taipale H, Tanskanen A, Tolppanen A, Tiihonen J, Hartikainen S, Tiihonen M. Long-term use of proton pump inhibitors among community-dwelling persons with and without Alzheimer's disease. Eur J Clin Pharmacol
2017:73(9):1149-1158.
|
|
365 |
Koponen M, Taipale H, Lavikainen P, Tanskanen A, Tiihonen J, Tolppanen A, Ahonen R, Hartikainen S. Antipsychotic Use and the Risk of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease. J Clin Psychiatry
2017:78(3):e257-e263.
|
|
366 |
Koponen M, Taipale H, Lavikainen P, Tanskanen A, Tiihonen J, Tolppanen AM, Ahonen R, Hartikainen S. Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease. J
Alzheimers Dis 2017:56(1):107-118.
|
|
367 |
Kuivalainen S, Vehviläinen-Julkunen K, Louheranta O, Putkonen A, Repo-Tiihonen E, Tiihonen J. Seasonal variation of hospital violence, seclusion and restraint in a forensic psychiatric hospital. Int J Law Psychiatry 2017:52:1-6.
|
|
368 |
Kuivalainen S, Vehviläinen-Julkunen K, Louheranta O, Putkonen A, Repo-Tiihonen E, Tiihonen J. De-escalation techniques used, and reasons for seclusion and restraint, in a forensic psychiatric hospital. Int J Ment Health Nurs
2017:26(5):513-524.
|
|
369 |
Lampela P, Tolppanen AM, Tanskanen A, Tiihonen J, Hartikainen S, Taipale H. Anticholinergic Exposure and Risk of Pneumonia in Persons with Alzheimer's Disease: A Nested Case-Control Study. J Alzheimers Dis 2017:56(1):119-128.
|
|
370 |
Lampela P, Tolppanen AM, Tanskanen A, Tiihonen J, Lavikainen P, Hartikainen S, Taipale H. Use of antidementia drugs and risk of pneumonia in older persons with Alzheimer's disease. Ann Med 2017:49(3):230-239.
|
|
371 |
Lindner P, Budhiraja M, Westerman J, Savic I, Jokinen J, Tiihonen J, Hodgins S. White matter correlates of psychopathic traits in a female community sample. Soc Cogn Affect Neurosci 2017:12(9):1500-1510.
|
|
372 |
Moga DC, Taipale H, Tolppanen A-M, Tanskanen A, Tiihonen J, Hartikainen S, Wu Q, Jicha GA, Gnjidic D. A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and Finland. Drugs Aging
2017:34(1):55-65.
|
|
373 |
Olubamwo O, Onyeka IN, Aregbesola A, Ronkainen K, Tiihonen J, Föhr J, Kauhanen J. Association between route of illicit drug administration and hospitalizations for infective endocarditis. SAGE Open Med 2017:5:2050312117740987.
|
|
374 |
Puranen A, Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S. Incidence of antidepressant use in community-dwelling persons with and without Alzheimer's disease: 13-year follow-up. Int J Geriatr Psychiatry
2017:32(1):94-101.
|
|
375 |
Saarelainen L, Tolppanen A-M, Koponen M, Tanskanen A, Sund R, Tiihonen J, Hartikainen S, Taipale H. Risk of Hip Fracture in Benzodiazepine Users With and Without Alzheimer Disease. J Am Med Dir Assoc 2017:18(1):87.e15-87.e21.
|
|
376 |
Taipale H, Koponen M, Tanskanen A, Lavikainen P, Sund R, Tiihonen J, Hartikainen S, Tolppanen A. Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease: a nationwide
matched cohort study. Alzheimers Res Ther 2017:9(1):59.
|
|
377 |
Taipale H, Koponen M, Tanskanen A, Lavikainen P, Tolppanen AM, Sund R, Tiihonen J, Hartikainen S. Use of benzodiazepines and related drugs is associated with a risk of stroke among persons with Alzheimer's disease. Int Clin Psychopharmacol
2017:32(3):135-141.
|
|
378 |
Taipale H, Tolppanen A, Koponen M, Tanskanen A, Lavikainen P, Sund R, Tiihonen J, Hartikainen S. Risk of pneumonia associated with incident benzodiazepine use among community-dwelling adults with Alzheimer disease. Can Med Assoc J
2017:189(14):E519-E529.
|
|
379 |
Taipale H, Tolppanen A-M, Tiihonen M, Tanskanen A, Lic P, Tiihonen J, Hartikainen S. No Association Between Proton Pump Inhibitor Use and Risk of Alzheimer's Disease. Am J Gastroenterol 2017:112(12):1802-1808.
|
|
380 |
Tanskanen A, Taipale H, Koponen M, Tolppanen AM, Hartikainen S, Ahonen R, Tiihonen J. Drug exposure in register-based research-An expert-opinion based evaluation of methods. PLoS ONE 2017:12(9):e0184070.
|
|
381 |
Tapiainen V, Hartikainen S, Taipale H, Tiihonen J, Tolppanen A-M. Hospital-treated mental and behavioral disorders and risk of Alzheimer's disease: A nationwide nested case-control study. Eur Psychiatry 2017:43:92-98.
|
|
382 |
Terevnikov V, Stenberg J, Tiihonen J, Burkin M, Joffe G. Add-on mirtazapine improves orgasmic functioning in patients with schizophrenia treated with first-generation antipsychotics. Nord J Psychiatry 2017:71(1):77-80.
|
|
383 |
Thomson A, Tiihonen J, Miettunen J, Virkkunen M, Lindberg N. Fire-setting performed in adolescence or early adulthood predicts schizophrenia: a register-based follow-up study of pre-trial offenders. Nord J Psychiatry 2017:71(2):96-101.
|
|
384 |
Tielbeek JJ, Johansson A, Polderman TJ, Rautiainen MR, Jansen P, Taylor M, Tong X, Lu Q, Burt AS, ..., Paunio T, Tiihonen J, ..., Posthuma D. Genome-Wide Association Studies of a Broad Spectrum of Antisocial Behavior. JAMA Psychiatry
2017:74(12):1242-1250.
|
|
385 |
Tiihonen J. Use of lithium in patients with unipolar depression - Author's reply. Lancet Psychiatry 2017:4(9):663.
|
|
386 |
Tiihonen J, Halonen P, Tiihonen L, Kautiainen H, Storvik M, Callaway J. The association of ambient temperature and violent crime. Sci Rep 2017:7(1):6543.
|
|
387 |
Tiihonen J, Mittendorfer-Rutz E, Majak M, Mehtälä J, Hoti F, Jedenius E, Enkusson D, Leval A, Sermon J, Tanskanen A, Taipale H. Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29?823 Patients With Schizophrenia. JAMA
Psychiatry 2017:74(7):686-693.
|
|
388 |
Tiihonen J, Tanskanen A, Hoti F, Vattulainen P, Taipale H, Mehtälä J, Lähteenvuo M. Pharmacological treatments and risk of readmission to hospital for unipolar depression in Finland: a nationwide cohort study. Lancet Psychiatry
2017:4(7):547-553.
|
|
389 |
Tolppanen A, Voutilainen A, Taipale H, Tanskanen A, Lavikainen P, Koponen M, Tiihonen J, Hartikainen S. Regional changes in psychotropic use among Finnish persons with newly diagnosed Alzheimer's disease in 2005-2011. PLoS ONE
2017:12(3):e0173450.
|
|
390 |
Tolppanen A-M, Taipale H, Hartikainen S. Head or brain injuries and Alzheimer's disease: A nested case-control register study. Alzheimers Dement 2017:13(12):1371-1379.
|
|
391 |
Tolppanen A-M, Taipale H, Koponen M, Tanskanen A, Lavikainen P, Paananen J, Tiihonen J, Hartikainen S. Screening approach for identifying candidate drugs and drug-drug interactions related to hip fracture risk in persons with Alzheimer disease.
Pharmacoepidemiol Drug Saf 2017:26(8):875-889.
|
|
392 |
Torvinen-Kiiskinen S, Tolppanen AM, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Taipale H. Antidepressant use and risk of hip fractures among community-dwelling persons with and without Alzheimer's disease. Int J Geriatr Psychiatry
2017:32(12):e107-e115.
|
|
393 |
Wingård L, Bodén R, Brandt L, Tiihonen J, Tanskanen A, Kieler H, Andersen M, Reutfors J. Reducing the rehospitalization risk after a manic episode: A population based cohort study of lithium, valproate, olanzapine, quetiapine and aripiprazole in
monotherapy and combinations. J Affect Disord 2017:217:16-23.
|
|
394 |
Joensuu M, Ahola P, Knekt P, Lindfors O, Saarinen P, Tolmunen T, Valkonen-Korhonen M, Vanninen R, Jääskeläinen T, Virtala E, Kuikka J, Tiihonen J, Lehtonen J. Baseline symptom severity predicts serotonin transporter change during psychotherapy in
patients with major depression. Psychiatry Clin Neurosci 2016:70(1):34-41.
|
|
395 |
Kivimies K, Repo-Tiihonen E, Kautiainen H, Maaranen P, Muhonen LH, Heikkinen M, Tiihonen J. Opioid abuse and hospitalization rates in patients with schizophrenia. Nord J Psychiatry 2016:70(2):128-32.
|
|
396 |
Kuokkanen R, Lappalainen R, Repo-Tiihonen E, Tiihonen J, Aho-Mustonen K. Cognitive insight, clinical insight, and reasoning in schizophrenia: a pilot study in a forensic setting. J Forensic Psychol Pract 2016:16(4):253-267.
|
|
397 |
Kärkkäinen O, Häkkinen MR, Auriola S, Kautiainen H, Tiihonen J, Storvik M. Increased steroid hormone dehydroepiandrosterone and pregnenolone levels in post-mortem brain samples of alcoholics. Alcohol 2016:52:63-70.
|
|
398 |
Lindner P, Savic I, Sitnikov R, Budhiraja M, Liu Y, Jokinen J, Tiihonen J, Hodgins S. Conduct disorder in females is associated with reduced corpus callosum structural integrity independent of comorbid disorders and exposure to maltreatment.
Transl Psychiatry 2016:6:e714.
|
|
399 |
Onyeka IN, Basnet S, Beynon CM, Tiihonen J, Tiihonen J, Föhr J, Kauhanen J. Association between routes of drug administration and all-cause mortality among drug users. J Subst Use 2016:21(6):559-565.
|
|
400 |
Rautiainen MR, Paunio T, Repo-Tiihonen E, Virkkunen M, Ollila HM, Sulkava S, Jolanki O, Palotie A, Tiihonen J. Genome-wide association study of antisocial personality disorder. Transl Psychiatry 2016:6(9):e883.
|
|
401 |
Rossi R, Pievani M, Järvenpää T, Testa C, Koskenvuo M, Räihä I, Kaprio J, Frisoni GB, Rinne JO, Laakso MP, Laakso MP. Voxel-based morphometry study on monozygotic twins discordant for Alzheimer's disease. Acta Neurol Scand
2016:133(6):427-33.
|
|
402 |
Saarelainen L, Taipale H, Koponen M, Tanskanen A, Tolppanen A-M, Tiihonen J, Hartikainen S, Tiihonen J, Hartikainen S. The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease. J Alzheimers Dis
2016:49(3):809-18.
|
|
403 |
Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S. Drug use in persons with and without Alzheimer's disease aged 90 years or more. Age Ageing 2016:45(6):900-904.
|
|
404 |
Taipale H, Purhonen M, Tolppanen AM, Tanskanen A, Tiihonen J, Hartikainen S. Hospital care and drug costs from five years before until two years after the diagnosis of Alzheimer's disease in a Finnish nationwide cohort. Scand J Public Health
2016:44(2):150-8.
|
|
405 |
Taipale H, Tanskanen A, Koponen M, Tolppanen AM, Tiihonen J, Hartikainen S. Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons. Clin Epidemiol 2016:8:363-371.
|
|
406 |
Tenkanen H, Taskinen H, Kontio R, Repo-Tiihonen E, Tiihonen J, Kinnunen J. Nurses' Time Use in Forensic Psychiatry: Core Interventions Outlined in the Finnish Clinical Practice Guideline on Schizophrenia. J Forensic Nurs
2016:12(2):64-73.
|
|
407 |
Thomson A, Tiihonen J, Miettunen J, Virkkunen M, Lindberg N, Tiihonen J. Hospital-treated suicide attempts among Finnish fire setters: a follow-up study. Crim Behav Ment Health 2016:26(5):395-402.
|
|
408 |
Tiihonen J, Mittendorfer-Rutz E, Torniainen M, Alexanderson K, Tanskanen A. Mortality and Cumulative Exposure to Antipsychotics, Antidepressants, and Benzodiazepines in Patients With Schizophrenia: An Observational Follow-Up Study. Am J
Psychiatry 2016:173(6):600-6.
|
|
409 |
Tiihonen J, Tiihonen J. Real-world effectiveness of antipsychotics. Editorial. Acta Psychiatr Scand 2016:134(5):371-373.
|
|
410 |
Tiihonen M, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S. Incidence and Duration of Cumulative Bisphosphonate Use among Community-Dwelling Persons with or without Alzheimer's Disease. J Alzheimers Dis 2016:52(1):127-32.
|
|
411 |
Tikkanen R, Saukkonen T, Fex M, Bennet H, Rautiainen MR, Paunio T, Koskinen M, Panarsky R, Bevilacqua L, Sjöberg RL, Tiihonen J, Virkkunen M. The effects of a HTR2B stop codon and testosterone on energy metabolism and beta cell function among
antisocial Finnish males. J Psychiatric Res 2016:81:79-86.
|
|
412 |
Tikkanen R, Saukkonen T, Fex M, Bennet H, Rautiainen MR, Paunio T, Koskinen M, Panarsky R, Bevilacqua L, Sjöberg RL, Tiihonen J, Tiihonen J, Virkkunen M. Influence of a HTR2B stop codon on glucagon homeostasis and glucose excursion in non-diabetic
men. Exp Clin Endocrinol Diabetes 2016:124(9):529-534.
|
|
413 |
Tolppanen A, Ahonen R, Koponen M, Lavikainen P, Purhonen M, Taipale H, Tanskanen A, Tiihonen J, Tiihonen M, Hartikainen S. Month and Season of Birth as a Risk Factor for Alzheimer's Disease: A Nationwide Nested Case-control Study. J Prev Med
Public Health 2016:49(2):134-8.
|
|
414 |
Tolppanen A, Taipale H, Koponen M, Lavikainen P, Tanskanen A, Tiihonen J, Hartikainen S. Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) study. BMJ Open 2016:6(7):e012100.
|
|
415 |
Tolppanen A, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S. Comparison of predictors of hip fracture and mortality after hip fracture in community-dwellers with and without Alzheimer's disease - exposure-matched cohort study. BMC Geriatr
2016:16(1):204.
|
|
416 |
Tolppanen AM, Koponen M, Tanskanen A, Lavikainen P, Sund R, Tiihonen J, Hartikainen S, Taipale H. Antipsychotic Use and Risk of Hospitalization or Death Due to Pneumonia in Persons With and Those Without Alzheimer Disease. Chest
2016:150(6):1233-1241.
|
|
417 |
Basnet S, Onyeka IN, Tiihonen J, Föhr J, Kauhanen J. Characteristics of drug-abusing females with and without children seeking treatment in Helsinki, Finland. Scand J Public Health 2015:43(3):221-8.
|
|
418 |
Koponen M, Taipale H, Tanskanen A, Tolppanen AM, Tiihonen J, Ahonen R, Hartikainen S. Long-term use of antipsychotics among community-dwelling persons with Alzheimer?s disease: A nationwide register-based study. Eur Neuropsychopharmacology
2015:25(10):1706-13.
|
|
419 |
Koponen M, Tolppanen AM, Taipale H, Tanskanen A, Tiihonen J, Johnell K, Fastbom J, Ahonen R, Hartikainen S. Incidence of antipsychotic use in relation to diagnosis of Alzheimer's disease among community-dwelling persons. Br J Psychiatry
2015:207(5):444-9.
|
|
420 |
Kuokkanen R, Aho-Mustonen K, Muotka J, Lappalainen R, Tiihonen J. A Pilot Study of Group Administered Metacognitive Training (MCT) for Schizophrenia Patients in a High-Security Forensic Setting: Subjective Training Success and Health-Related Quality
of Life. J Forensic Psychol Pract 2015:15(4):344-362.
|
|
421 |
Kupila J, Kärkkäinen O, Laukkanen V, Häkkinen M, Kautiainen H, Tiihonen J, Storvik M. (3H)Ifenprodil binding in post-mortem brains of cloninger type 1 and 2 alcoholics: A whole-hemisphere autoradiography study . Psychiatry Res
2015:231(3):197-201.
|
|
422 |
Kurko TA, Saastamoinen LK, Tähkäpää S, Tuulio-Henriksson A, Taiminen T, Tiihonen J, Airaksinen MS, Hietala J. Long-term use of benzodiazepines: Definitions, prevalence and usage patterns - a systematic review of register-based studies. Eur
Psychiatry 2015:30(8):1037-47.
|
|
423 |
Kärkkäinen O, Laukkanen V, Haukijärvi T, Kautiainen H, Tiihonen J, Storvik M. Lower [3H]Citalopram binding in brain areas related to social cognition in alcoholics. Alcohol Alcohol 2015:50(1):46-50.
|
|
424 |
Laakso MP, Jukarainen NM, Vepsäläinen J. Diagnosis of dementias by high-field 1H MRS of cerebrospinal fluid. J Neurol Neurosurg Psychiatry 2015:86(12):1286-90.
|
|
425 |
Laukkanen V, Kärkkäinen O, Kupila J, Kautiainen H, Tiihonen J, Storvik M. Increased metabotropic glutamate 2/3 receptor binding in the perigenual anterior cingulate cortex of cloninger type 2 alcoholics: a whole-hemisphere autoradiography study.
Alcohol Alcohol 2015:50(1):62-67.
|
|
426 |
Laukkanen V, Laukkanen V, Kärkkäinen O, Kautiainen H, Tiihonen J, Storvik M. Decreased [³H]naloxone Binding in the Dentate Gyrus of Cloninger Type 1 Anxiety-Prone Alcoholics: A Postmortem Whole-Hemisphere Autoradiography Study. Alcohol Clin Exp
Res 2015:39(8):1352-9.
|
|
427 |
Ojala KP, Tiihonen J, Repo-Tiihonen E, Tikkanen R, Virkkunen M. Basal insulin secretion, PCL-R and recidivism among impulsive violent alcoholic offenders. Psychiatry Res 2015:225(3):420-4.
|
|
428 |
Ojansuu I, Putkonen H, Tiihonen J. Mortality among forensic psychiatric patients in Finland. Nord J Psychiatry 2015:69(1):25-7.
|
|
429 |
Onyeka IN, Beynon CM, Ronkainen K, Tiihonen J, Föhr J, Kuikanmäki O, Paasolainen M, Kauhanen J. Hospitalization in a cohort seeking treatment for illicit drug use in Finland. J Subst Abuse Treat 2015:53:64-70.
|
|
430 |
Onyeka IN, Beynon CM, Vohlonen I, Tiihonen J, Föhr J, Ronkainen K, Kauhanen J. Potential Years of Life Lost Due to Premature Mortality Among Treatment-Seeking Illicit Drug Users in Finland. J Community Health 2015:40(6):1099-106.
|
|
431 |
Onyeka IN, Olubamwo O, Beynon CM, Ronkainen K, Förh J, Tiihonen J, Tuomola P, Tasa N, Kauhanen J. Factors Associated with Hospitalization for Blood-Borne Viral Infections Among Treatment-Seeking Illicit Drug Users. J Subst Abuse Treat
2015:53:71-77.
|
|
432 |
Putkonen A. Recovery From Cervical Dystonia With Topiramate. J Med Cases 2015:6(8):373-375.
|
|
433 |
Saarelainen L, Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S. The Incidence of Benzodiazepine and Related Drug Use in Persons with and without Alzheimer's Disease. J Alzheimers Dis 2015:49(3):809-18.
|
|
434 |
Scheen L, Brandt L, Bodén R, Tiihonen J, Andersen M, Kieler H, Reutfors J. Predictors for initiation of pharmacological prophylaxis in patients with newly diagnosed bipolar disorder - A nationwide cohort study. J Affect Disord
2015:172:204-210.
|
|
435 |
Taipale H, Koponen M, Tanskanen A, Tolppanen A, Tiihonen J, Hartikainen S. Long-term use of benzodiazepines and related drugs among community-dwelling individuals with and without Alzheimer's disease. Int Clin Psychopharmacol
2015:30(4):202-8.
|
|
436 |
Taipale H, Vuorikari H, Tanskanen A, Koponen M, Tiihonen J, Kettunen R, Hartikainen S. Prevalence of Drug Combination Increasing Bleeding Risk Among Warfarin Users With and Without Alzheimers Disease. Drugs Aging 2015:32(11):937-45.
|
|
437 |
Tanskanen A, Taipale H, Koponen M, Tolppanen AM, Hartikainen S, Ahonen R, Tiihonen J. From prescription drug purchases to drug use periods - a second generation method (PRE2DUP). BMC Med Inform Decis Mak 2015:15:21.
|
|
438 |
Thomson A, Tiihonen J, Miettunen J, Sailas E, Virkkunen M, Lindberg N. Psychopathic traits among a consecutive sample of Finnish pretrial fire-setting offenders. BMC Psychiatry 2015:15:44.
|
|
439 |
Thomson A, Tiihonen J, Miettunen J, Virkkunen M, Lindberg N. Mortality of firesetters: a follow-up study of Finnish male firesetters who underwent a pretrial forensic examination in 1973-1998. Psychiatry Res 2015:225(3):638-42.
|
|
440 |
Tiihonen J, Lehti M, Aaltonen M, Kivivuori J, Kautiainen H, Virta L, Hoti F, Tanskanen A, Korhonen P. Psychotropic drugs and homicide: A prospective cohort study from Finland. World Psychiatry 2015:14(2):245-247.
|
|
441 |
Tiihonen J, Rautiainen MR, Ollila HM, Repo-Tiihonen E, Virkkunen M, Palotie A, Pietiläinen O, Kristiansson K, Joukamaa M, Lauerma H, Saarela J, Tyni S, Vartiainen H, Paananen J, Goldman D, Paunio T. Genetic background of extreme violent behavior.
Mol Psychiatry 2015:20(6):786-92.
|
|
442 |
Tikkanen R, Tiihonen J, Rautiainen MR, Paunio T, Bevilacqua L, Panarsky R, Goldman D, Virkkunen M. Impulsive alcohol-related risk-behavior and emotional dysregulation among individuals with a serotonin 2B receptor stop codon. Transl Psychiatry
2015:5:e681.
|
|
443 |
Torniainen M, Mittendorfer-Rutz E, Tanskanen A, Björkenstam C, Suvisaari J, Alexanderson K, Tiihonen J. Antipsychotic Treatment and Mortality in Schizophrenia. Schizophr Bull 2015:41(3):656-63.
|
|
444 |
Hallikainen I, Martikainen J, Lin PJ, Cohen J T, Lahoz R, Välimäki T, Hongisto K, Väätäinen S, Vanhanen M, Neumann P J, Hänninen T, Koivisto AM. The Progression of Alzheimer's Disease Can Be Assessed with a Short Version of the CERAD
Neuropsychological Battery: The Kuopio ALSOVA Study. Dement Geriatr Cogn Disord Extra 2014(4):494-508.
|
|
445 |
Husso M, Sipola P, Kuittinen T, Manninen H, Vainio P, Hartikainen J, Saarakkala S, Töyräs J, Kuikka J. Assessment of myocardial perfusion with MRI using a modified dual bolus method. Physiol Meas 2014:35(4):533-547.
|
|
446 |
Kivimies K, Repo-Tiihonen E, Kautiainen H, Tiihonen J. Previous forensic mental examination is a useful marker indicating effective violence relapse prevention among psychotic patients. Nord J Psychiatry 2014:68(5):311-5.
|
|
447 |
Koskinen L1, Likitalo H, Aho J, Vuorio O, Meretoja R. The professional competence profile of Finnish nurses practising in a forensic setting. J Psychiatr Mental Health Nurs 2014:21(4):320-6.
|
|
448 |
Kuivalainen S, Vehviläinen-Julkunen K, Putkonen A, Louheranta O, Tiihonen J. Violent behaviour in a forensic psychiatric hospital in Finland: an analysis of violence incident reports. J Psychiatr Mental Health Nurs 2014:21(3):214-8.
|
|
449 |
Kuokkanen R, Lappalainen R, Repo-Tiihonen E, Tiihonen J. Metacognitive group training for forensic and dangerous non-forensic patients with schizophrenia: A randomised controlled feasibility trial. Crim Behav Ment Health
2014:24(5):345-57.
|
|
450 |
Lebel JL, Duxbury JA, Putkonen A, Sprague T, Rae C, Sharpe J. Multinational experiences in reducing and preventing the use of restraint and seclusion. J Psychosoc Nurs Ment Health Serv 2014:52(11):22-9.
|
|
451 |
Mittendorfer-Rutz E, Härkänen T, Tiihonen J, Haukka J. Association of Socio-Demographic Factors, Sick-Leave and Health Care Patterns with the Risk of Being Granted a Disability Pension among Psychiatric Outpatients with Depression. PLoS ONE
2014:9(6):e99869.
|
|
452 |
Onyeka IN, Beynon CM, Hannila ML, Tiihonen J, Föhr J, Tuomola P, Kuikanmäki O, Tasa N, Paasolainen M, Kauhanen J. Patterns and 14-year trends in mortality among illicit drug users in Finland: the HUUTI study. Int J Drug Policy
2014:25(6):1047-53.
|
|
453 |
Solje E, Hartikainen P, Valori M, Vanninen R, Tiihonen J, Hakola P, Tienari PJ, Remes AM. The C9ORF72 expansion does not affect the phenotype in Nasu-Hakola disease with the DAP12 mutation. Neurobiol Aging 2014:35(7):1780e13-7.
|
|
454 |
Taipale H, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S. High prevalence of psychotropic drug use among persons with and without Alzheimer's disease in Finnish nationwide cohort. Eur Neuropsychopharmacology
2014:24(11):1729-37.
|
|
455 |
Taipale H1, Koponen M, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S. Antipsychotic doses among community-dwelling persons with Alzheimer disease in Finland. J Clin Psychopharmacol 2014:34(3):435-40.
|
|
456 |
Taipale H1, Koponen M1, Tanskanen A2, Tolppanen AM3, Tiihonen J, Hartikainen S. Antipsychotic Polypharmacy among a Nationwide Sample of Community-Dwelling Persons with Alzheimer's Disease. J Alzheimers Dis 2014:41(4):1223-8.
|
|
457 |
Taipale H1, Tanskanen A, Koponen M, Tolppanen AM, Tiihonen J, Hartikainen S. Antidementia drug use among community-dwelling individuals with Alzheimer's disease in Finland: a nationwide register-based study. Int Clin Psychopharmacol
2014:29(4):216-23.
|
|
458 |
Tanskanen A1, Taipale H, Koponen M, Tolppanen AM, Hartikainen S, Ahonen R, Tiihonen J. From prescriptions to drug use periods - things to notice. BMC Res Notes 2014:7:796.
|
|
459 |
Tiwari AK, Need AC, Lohoff FW, Zai CC, Chowdhury NI, Müller DJ, Putkonen A, Repo-Tiihonen E, Hallikainen T, Yagcioglu AE, Tiihonen J, Kennedy JL, Meltzer HY. Exome sequence analysis of Finnish patients with clozapine-induced agranulocytosis. Mol
Psychiatry 2014:19(4):403-5.
|
|
460 |
Torvinen-Kiiskinen S, Taipale H, Tanskanen A, Tiihonen J, Hartikainen S. Concomitant use of acetylcholine esterase inhibitors and urinary antispasmodics among Finnish community-dwelling persons with Alzheimer disease. J Clin Psychopharmacol
2014:34(6):722-7.
|
|
461 |
Uosukainen H, Ilomäki J, Kauhanen J, Tacke U, Föhr J, Tiihonen J, Bell JS. Factors associated with buprenorphine compared to amphetamine abuse among clients seeking treatment in Finland. J Subst Abuse Treat 2014:46(5):561-566.
|
|
462 |
Boccardi M, Bocchetta M, Aronen HJ, Repo-Tiihonen E, Vaurio O, Thompson PM, Tiihonen J, Frisoni GB. Atypical nucleus accumbens morphology in psychopathy: Another limbic piece in the puzzle. Int J Law Psychiatry 2013:36:157-167.
|
|
463 |
Kauppila E, Vanninen E, Kaurijoki S, Karhunen L, Pietiläinen KH, Rissanen A, Tiihonen J, Pesonen U, Kaprio J. Influence of serotonin transporter gene polymorphism (5-HTTLPR Polymorphism) on the relation between brain 5-HT transporter binding and
heart rate correcrted cardiac repolarization interval. PLoS ONE 2013:8(1):e50303.
|
|
464 |
Kuosmanen A, Tiihonen J, Repo-Tiihonen E, Eronen M, Turunen H. Patient safety culture in two Finnish state-run forensic psychiatric hospitals. J Forensic Nurs 2013:9(4):207-216.
|
|
465 |
Kupila J, Kärkkäinen O, Laukkanen V, Tupala E, Tiihonen J, Storvik M. mGluR1/5 receptor densities in the brains of alcoholic subjects: A whole-hemisphere autoradiography study. Psychiatry Res Neuroimaging 2013:212:245-250.
|
|
466 |
Kärkkäinen O, Kupila J, Häkkinen M, Laukkanen V, Tupala E, Kautiainen H, Tiihonen J, Storvik M. AMPA receptors in post-mortem brains of Cloninger type 1 and 2 alcoholics: A whole-hemisphere autoradiography study. Psychiatry Res Neuroimaging
2013:214:429-434.
|
|
467 |
Kärkkäinen OK, Lehtonen M, Laukkanen V, Tupala E, Hyytiä P, Kautiainen H, Tiihonen J, Callaway JC, Storvik M. Endogenous cannabinoids in amygdala and hippocampus in post-mortem brains of Cloninger type 1 and 2 alcoholics. Alcohol
2013:47:399-403.
|
|
468 |
Laukkanen V, Storvik M, Häkkinen M, Akamine Y, Tupala E, Virkkunen M, Tiihonen J. Decreased GABA(A) benzodiazepine binding site densities in postmortem brains of Cloninger type 1 and 2 alcoholics. Alcohol 2013:47:103-108.
|
|
469 |
Michel SF, Riaz M, Webster C, Hart SD, Levander S, Müller-Isberner R, Tiihonen J, Repo-Tiihonen E, Tuninger E, Hodgins S. Using the HCR-20 to predict aggressive behavior among men with schizophrenia living in the community: Accuracy of prediction,
general and forensic settings, and dynamic risk factors. Int J Forensic Ment Health 2013:12(1):1-13.
|
|
470 |
Miles SW, Sheridan J, Russell B, Kydd R, Wheeler A, Walters C, Gamble G, Hardley P, Jensen M, Kuoppasalmi K, Tuomola P, Föhr J, Kuikanmäki O, Vorma H, Salokangas R, Mikkonen A, Kallio M, Kauhanen J, Kiviniemi V, Tiihonen J. Extended-release
methylphenidate for treatment of amphetamine/methamphetamine dependence: a randomized, double-blind, placebo-controlled trial. Addiction 2013:108(7):1279-1286.
|
|
471 |
Onyeka IN, Beynon CM, Uosukainen H, Korhonen MJ, Ilomäki J, Bell JS, Paasolainen M, Tasa N, Tiihonen J, Kauhanen J. Coexisting social conditions and health problems among clients seeking treatment for illicit drug use in Finland: The HUUTI study.
BMC Public Health 2013:13:380.
|
|
472 |
Putkonen A, Kuivalainen S, Louheranta O, Repo-Tiihonen E, Ryynänen OP, Kautiainen H, Tiihonen J. Cluster-randomized controlled trial of reducing seclusion and restraint in secured care of men with schizophrenia. Psychiatr Serv
2013:64(9):850-855.
|
|
473 |
Stenberg J-H, Terevnikov V, Joffe M, Tiihonen J, Chukhin E, Burkin M, Joffe G. Predictors and mediators of add-on mirtazapine-induced cognitive enhancement in schizophrenia - A path model investigation. Neuropharmacology
2013:64:248-253.
|
|
474 |
Suokas JT, Suvisaari JM, Haukka J, Korhonen P, Tiihonen J. Description of long-term polypharmacy among schizophrenia outpatiens. Soc Psychiatry Psychiatr Epidemiol 2013:48:631-638.
|
|
475 |
Terevnikov V, Stenberg J-H, Tiihonen J, Chukhin E, Joffe M, Burkin M, Joffe G. Relationships between pharmacotherapy-induced metabolic changes and improved psychopathology in schizophrenia: data from a mirtazapine and first-genedation antipsychotics
combination trial. Int J Neuropsychopharmacol 2013:16:1661-1666.
|
|
476 |
Tiihonen J, Leucht S. Clozapine resistance - Augmentation strategies. Eur Neuropsychopharmacology 2013:23:338.
|
|
477 |
Toivonen P, Könönen M, Niskanen E, Vaurio O, Repo-Tiihonen E, Seppänen A, Aronen HJ, Vanninen R, Tiihonen J, Laakso M. Cavum septum pellucidum and psychopathy. Br J Psychiatry 2013(203):152-153.
|
|
478 |
Tolppanen A-M, Taipale H, Koponen M, Lavikainen P, Tanskanen A, Tiihonen J, Hartikainen S. Use of existing data sources in clinical epidemiology: Finnish health care registers in Alzheimer's disease research - the Medication use among persons with
Alzheimer's disease (MEDALZ-2005) study. Clin Epidemiol 2013:5:277-285.
|
|
479 |
Uosukainen H, Kauhanen J, Bell JS, Ronkainen K, Tiihonen J, Föhr J, Onyeka IN, Korhonen MJ. Mortality among clients seeking treatment for buprenorphine abuse in Finland. Drug Alcohol Depend 2013:133:391-397.
|
|
480 |
Uosukainen H, Kauhanen J, Voutilainen S, Föhr J, Paasolainen M, Tiihonen J, Laitinen K, Onyeka IN, Bell JS. Twelve-year trend in treatment seeking for buprenorphine abuse in Finland. Drug Alcohol Depend 2013:127:207-214.
|
|
481 |
Vanhanen M, Hakola P, Ilonen T, Tiihonen J. Word list learning in patients with polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy. Dement Geriatr Cogn Disord 2013:3:10-15.
|
|
482 |
Hallikainen I, Koivisto AM, Paajanen T, Hiltunen A, Karppi P, Vanhanen M, Välimäki T, Herukka S-K, Soininen H, Hänninen T. Cognitive and neuropsychiatric symptom differences in early stages of Alzheimer's Disease: Kuopio ALSOVA Study. Dement
Geriatr Cogn Disord 2012:2:209-218.
|
Artikkelit kv. tiet. kokoomateoksissa ja konf.julkaisuissa
Articles in intl. scientific edited books and refereed proceedings
|
|
483 |
Hamina A, Skurtveit S, Hoffmann M. Drugs utilization research in specific therapeutic areas-opioids. In: Elseviers M, Wettermark B, Benkö R et al, eds. Drug Utilization Research: Methods and Applications, 2nd edition. Wiley, 2024.
|
|
484 |
Paloneva J, Autti T, Hakola P, Haltia MJ. Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy. In: Adam MP, Ardinger HH, Pagon RA, et al, eds. GeneReviews [Internet], https://www.ncbi.nlm.nih.gov/books/. Seattle (WA),
USA: University of Washington, 2020.
|
Artikkelit kansallisissa tieteellisissä aikakauslehdissä
Articles in national refereed scientific journals
|
|
485 |
Lieslehto J, Sanmark E, Tiihonen J, Seppänen A. Tekoäly psykiatrin työkaluna: haasteet, mahdollisuudet ja tulevaisuuden suuntaviivat. Suomen Lääkärilehti 2025:80(2):115-118.
|
|
486 |
Bergström T, Hulkko A, Hartikainen S, Koponen H, Lieslehto J, Jääskeläinen E, Isohanni M. Psykoosilääkehoidon ohjaus voi tehostaa skitsofrenian hoitoa. Duodecim 2022:138(9):787-793.
|
|
487 |
Tiihonen J, Ojansuu I, Lehti M. Päihdekäyttö ja riski syyllistyä muita vaarantaviin tekoihin. Duodecim 2021:137(22):2461-2466.
|
|
488 |
Ahlgrén-Rimpiläinen A, Joelsson P, Kaarre H, Rautanen M, Niinistö K, Lindberg N, Tiihonen J. Vaarallisuuden arviointi - sattuman summaako. Edilex 2020:41:1-30.
|
|
489 |
Ahola P, Härkänen T, Lehtonen J, Lindfors O, Knekt P, Joensuu M, Saarinen P, Tolmunen T, Virtala E, Tiihonen J, Valkonen-Korhonen M. Concordance and discordance in how patients and therapists experience the psychotherapy process in the treatment of
depression. Psychiatr Fenn 2020:51:122-141.
|
|
490 |
Kettunen R, Suvisaari J, Tiihonen J, Ruskoaho H, Huikuri H. Psyykenlääkkeet ja sydän. Duodecim 2020:136(2):1411-8.
|
|
491 |
Liehu M, Tiihonen M, Taipale H, Tanskanen A, Tiihonen J, Tolppanen A-M, Hartikainen S, Koponen M. Psykoosilääkkeiden käyttö on pitkäkestoista Alzheimerin tautia sairastavilla. Dosis 2020:2020(36):6-23.
|
|
492 |
Juhola L, Taipale H, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen A-M. Alzheimer-potilaat ja psyykenlääkkeiden käyttö 2005-2011. Suomen Lääkärilehti 2019:74(10):609-616.
|
|
493 |
Kuosmanen L, Laukkanen E. Pakon käytön vähentäminen psykiatrisessa sairaalahoidossa. Duodecim 2019:135(10):925-931.
|
|
494 |
Kurko T, Saastamoinen L, Tuulio-Henriksson A, Taiminen T, Tiihonen J, Airaksinen M, Hietala J. Bentsodiatsepiinien pitkäaikaiskäyttö on vähentynyt. Suomen Lääkärilehti 2018:73(20):1292-1299.
|
|
495 |
Lähteenvuo M, Antolin-Concha D, Vattulainen P, Tanskanen A, Taipale H, Tiihonen J. Psychopharmacological treatment, mortality and suicide in bipolar disorder in a Finnish nationwide cohort of 18,018 patients. Psychiatr Fenn
2018:49:10-21.
|
|
496 |
Rauhala A, Kinnunen M, Kuosmanen A, Liukka M, Olin K, Sahlström M, Roine RP. Mitä vapaaehtoiset vaaratapahtumailmoitukset kertovat? Suomen Lääkärilehti 2018:73(46):2716-2720.
|
|
497 |
Kauhanen J, Tiihonen J. Huumeiden terveysriskit Suomessa - voiko niitä hallita? HUUTI-tutkimuksen antia. Duodecim 2017:133(1):34-42.
|
|
498 |
Tiihonen J, Mittendorfer-rutz E, Majak M, Mehtälä J, Hoti F, Jedenius E, Enkusson D, Leval A, Sermon J, Tanskanen A, Taipale H. Psykoosilääkityksen vaikuttavuus skitsofrenian hoidossa. Duodecim 2017:133(15):1412.
|
|
499 |
Louheranta O, Lähteenvuo M, Lähteenvuo M, Kangasniemi M. Henkinen ja hengellinen tuki terveydenhuollossa kenen vastuulla? . Sosiaalilääketieteellinen aikakauslehti 2016:53(4):234-241.
|
|
500 |
Repo-Tiihonen E, Hallikainen T. Epäsosiaalinen persoonallisuushäiriö. Duodecim 2016:132(2):130-6.
|
|
501 |
Taipale H, Tolppanen A-M, Purhonen M, Tanskanen A, Ahonen R, Tiihonen J, Hartikainen S. Alueelliset erot sairaalapäivissä ja lääkekustannuksissa Alzheimerin tautia sairastavilla ja verokeilla. Suomen Lääkärilehti 2016:71(22):1613-1619.
|
|
502 |
Hallikainen T, Repo-Tiihonen E. Psykoottisen potilaan aggressio - ehkäisy ja hoito. Duodecim 2015:131(15):1361-6.
|
|
503 |
Tolmunen T, Suonmaa E, Ruusunen A, Voutilainen S, Lehto S. Tehoavatko omega-3-rasvahapot nuorten mielenterveys- ja oppimishäiriöihin? Suomen Lääkärilehti 2015:70(41):2695-2701.
|
|
504 |
Lindsberg PJ, Castrén E, ..., Isometsä E, Kalso E, Marttunen M, Pihko H, Tienari P, Wartiovaara A, Jäkälä P, Kälviäinen R, Soininen H, Tiihonen J, Karlsson H, Rinne J, Roine RO, Elovaara I, Tamminen T, Öhman J, Majamaa K, Hari R. Aivosairaudet ovat
kalleimmat kansantautimme. Duodecim 2014:130(17):1721-30.
|
|
505 |
Purhonen M, Koponen H, Tiihonen J, Tanskanen A. Kun psyykenlääke vain katoaa. Pääkirjoitus. Duodecim 2014:130:438-439.
|
|
506 |
Tuppurainen H, Kivistö P, Repo-Tiihonen E, Tiihonen J. Skitsofrenian Käypä hoito -suosituksen toteutuminen Niuvanniemen sairaalassa. Suomen Lääkärilehti 2014:69(40):2549-2553.
|
|
507 |
Tiihonen J. Voisiko luonnon oma säilöntäaine mullistaa psykoosin hoidon? Pääkirjoitus. Duodecim 2013:129:2098-2099.
|
Tieteelliset monografiat
Scientific monographs
|
|
508 |
Rytkönen M. Kehityskulkuja ja väliintuloja. Ekologinen näkökulma vakavan väkivallanteon tehneiden nuorten sosioemotionaalisen terveyden kehitykseen. Väitöskirja. Kuopio: 2013. Publications of the University of Eastern Finland. Dissertations in
Health Sciences 177. 137 s.
|
Muut tieteelliset julkaisut
Other scientific publications
|
|
509 |
Hartikainen M. Real-World Effectiveness of Pharmacological Treatments of Alcohol, Opioid and Amphetamine Use Disorders - Findings from Swedish National Register-Based Studies. Doctoral dissertation. Kuopio: University of Eastern Finland, 2024.
Publications of the University of Eastern Finland. Dissertations in Health Sciences 822. 132 p.
|
|
510 |
Asikainen J. Prevention Of Coercive Action In Forensic Psychiatric Inpatient Care - Use Of Debriefing. Doctoral dissertation. Kuopio: University of Eastern Finland, 2022. Publications of the University of Eastern Finland. Dissertations in
Health Sciences 696. 111 p.
|
|
511 |
Lintunen J. Drug Repurposing in Severe Mental Disorders. Findings from Nationwide Register-Based Studies. Doctoral dissertation. Kuopio: University of Eastern Finland, 2022. Publications of the University of Eastern Finland. Dissertations in
Health Sciences 695. 138 p.
|
|
512 |
Kuosmanen A. Patient Safety Culture in Forensic Psychiatric Hospital Care. Health Care Staff Perceptions'. Doctoral dissertation. Kuopio: University of Eastern Finland, 2021. Publications of the University of Eastern Finland. Dissertations in
Health Sciences 648. 89 p.
|
|
513 |
Laukkanen E. Coercive Measures in Finnish Psychiatric Inpatient Care: Special Emphasis on Psychiatric Nursing Managers' Attitudes. Doctoral dissertation. Kuopio: University of Eastern Finland, 2021. Publications of the University of Eastern
Finland. Dissertations in Health Sciences 608. 110 p.
|
|
514 |
Stenius J. The Rorschach Ego Impairment Index (EII-2) as a predictor of psychotherapy outcome and alliance development. Doctoral dissertation. Jyväskylä: University of Jyväskylä, 2021. JYU Dissertations 378. 74 p.
|
|
515 |
Joensuu M. Serotonin transporter availability in major depression. Single photon emission tomography studies on drug-naļve depressed subjects: comparison with healthy subjects, effect of genotype, and follow-up during psychodynamic
psychotherapy. Doctoral dissertation. Kuopio: University of Eastern Finland, 2019. Publications of the University of Eastern Finland. Dissertations in Health Sciences 513. 74 p.
|
|
516 |
Tanskanen A. Drug Use Modelling Method PRE2DUP. From Prescriptions to Drug Use Periods. Doctoral dissertation. Kuopio: University of Eastern Finland, 2019. Publications of the University of Eastern Finland. Dissertations in Health Sciences
514. 59 p.
|
|
517 |
Kivimies K. Amphetamine, Cannabis and Opioid Use Disorders in Forensic Patients and in Schizophrenia. Doctoral dissertation. Kuopio: University of Eastern Finland, 2018. Publications of the University of Eastern Finland. Dissertations in
Health Sciences 468. 52 p.
|
|
518 |
Tuovinen S. Reduction of Seclusion and Restraint and Hospital Violence During Involuntary Forensic Psychiatric Care. Doctoral dissertation. Kuopio: UEF, 2017. Publications of the University of Eastern Finland. Dissertations in Health Sciences
446. 54., append.
|
|
519 |
Laukkanen V, Laukkanen V. Alterations in the neurotransmitter receptor binding densities in cloninger type 1 and 2 alcoholics. Doctoral dissertation. Kuopio: University of Eastern Finland, 2016. Publications of the University of Eastern
Finland. Dissertations in Health Sciences 355. 76 p.
|
Oppikirjat, patentit, esitelmät, abstraktit ym.
Textbooks, patents, presentations, abstracts etc.
|
|
520 |
Särkilä H, Taipale H, Niemelä S. Ketkä päätyvät suuriannoksiseen bentsodiatsepiinien käyttöön? Duodecim 2025:141(12):969-71.
|
|
521 |
Lieslehto J, Tiihonen J, Lähteenvuo M, Tanskanen A, Taipale H. Skitsofreniapotilaiden sitoutuminen psykoosilääkitykseen vaihtelee. Duodecim 2022:138(8):731.
|
|
522 |
Tiihonen J. Lääkehoito voi vähentää psyykkisiin sairauksiin liittyvää ennenaikaista kuolleisuutta. Suomen Lääkärilehti 2022:77(47-48):1999.
|
|
523 |
Tiihonen J. Vuoden 2022 Matti Äyräpään palkinnon saaja Jari Tiihonen; Lääkehoitojen vaikuttavuustutkimus vie kohti dataohjautuvaa terveydenhuoltoa. Duodecim 2022:138(23):2091-2092.
|
|
524 |
Tiihonen J, Kataja V, Lähteenvuo M, Taipale H. Prolaktiinipitoisuutta suurentavat psykoosilääkkeet ja rintasyöpäriski rekisteritiedon valossa. Duodecim 2022:138(4):296-298.
|
|
525 |
Tiihonen J, Tanskanen A, Bell JS, Dawson JL, Kataja V, Taipale H. Klotsapiinihoitoon liittyy suurentunut hematologisen syövän riski. Duodecim 2022:138(9):843.
|
|
526 |
Heikkinen M, Taipale H, Tanskanen A, Mittendorfer-rutz E, Lähteenvuo M, Tiihonen. Naltreksoni vähentää alkoholiongelmaisten sairaalahoitoja. Duodecim 2021:137(4):427.
|
|
527 |
Nummenmaa L, Lukkarinen L, Sun L, Putkinen V, Seppälä K, Karjalainen T, Karlsson HK, Hudson M, Venetjoki N, Salomaa M, Rautio P, Hirvonen J, Lauerma H, Tiihonen J. Psykopatian aivomekanismit selviävät. Duodecim 2021:137(9):991-992.
|
|
528 |
Taipale H, Särkilä H, Tanskanen A, Kurko T, Taiminen T, Tiihonen J, Sund R, Tuulio-henriksson A, Saastamoinen L, Hietala J:. Bentsodiatsepiinien käyttö pitkäaikaistuu yli kolmasosalla aloittajista. Duodecim 2021:137(1):103.
|
|
529 |
Tiihonen J. Oikeuspsykiatria. Kirjassa: Lönnqvist J, Henriksson M, Marttunen M, Partonen T, toim. Psykiatria, s. 825-843. Helsinki: Duodecim, 2021.
|
|
530 |
Tiihonen J, Koskuvi M, Lähteenvuo M, Virtanen PL, Ojansuu I, Vaurio O, Gao Y, Hyötyläinen I, Puttonen KA, Repo-Tiihonen E, Paunio T, Rautiainen M, Tyni S, Koistinaho J, Lehtonen S. Correction: Neurobiological roots of psychopathy. Mol
Psychiatry 2020:25(12):3455-3456.
|
|
531 |
Tiihonen J. Skitsofrenian lääkehoito. Duodecim 2019:135(20):2021-7.
|
|
532 |
Kuosmanen A, Liukka M, Aaltonen L-M, Roine RP, Kinnunen M. Pääsyy vai syypää - potilasturvallisuuskulttuuri ratkaisee. Suomen Lääkärilehti 2018:73(8):518-519.
|
|
533 |
Tiihonen J. Oikeuspsykiatria. Kirjassa: Lönnqvist J, Marttunen M, Henriksson M, Partonen T, toim. Psykiatria, s. pkr02500. Duodecim, 2017.
|
|
534 |
Makkonen P, Putkonen A, Korhonen J, Kuosmanen L, Kärkkäinen J. Pakon käytön vähentäminen ja turvallisuuden lisääminen psykiatrisessa hoidossa. Helsinki: Terveydenhuollon ja hyvinvoinnin laitos, 2016. THL Työpaperi 35. 44 s.
|
|
535 |
Keränen T, Kaski M, Scheinin M, Rinne J, Repo-Tiihonen E, Vartiainen H, Halila R, Heinonen S, Halkoaho A, Bendel S, Uusaro A, Turgut T, Roine RO, Launis V, Pasternack A. Kliininen tutkimus erityisryhmille. Kirjassa: Tapani Keränen, Amos Pasternack.,
toim. Kliinisen tutkimuksen etiikka : opas tutkijoille ja eettisille toimikunnille., s. 62-83. Helsinki: Duodecim, 2015.
|
|
536 |
Repo-Tiihonen E. Vaikeaa psykiatrista sairautta sairastavat ja oikeuspsykiatriset potilaat. Kirjassa: Keränen Tapani, Amos Pasternack, toim. Kliinisen tutkimuksen etiikka: opas tutkijoille ja eettisille toimikunnille, s. 70-73. Helsinki:
Duodecim, 2015.
|
|
537 |
Tiihonen J. Oikeuspsykiatria. Kirjassa: Lönnqvist J, Henriksson M, Marttunen M, Partonen T, toim. Psykiatria, s. 697-715. Helsinki: Duodecim, 2014.
|
|
538 |
Askola R, Nikkonen M, Vuorio O, Kylmä J. Oikeuspsykiatrisen potilaan toivottomuus ja toivo hoitosuhteessa. Pro terveys 2013(2):20-22.
|
|
539 |
Tiihonen E. Epäsosiaalinen persoonallisuushäiriö. Lääkärin käsikirja - viimeisin muutos 12.4.2013.
|
|
540 |
Lehtonen J, Tiihonen J, Joensuu MMO, Lehto SM, Ahola PO, Saarinen PI, Valkonen-Korhonen M, Tolmunen T, Kuikka JT. Toward molecular psychotherapy of depression? In: Levy RA, Ablon JS, Kächele H, eds. Psychodynamic Psychotherapy Research, p.
219-232. New York: Springer, 2012.
|